[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fpo8k2mx-U5NieIWH44iTX45xhb_CZDKyySmf8Ahrd98":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":34,"phaseBuckets":84,"rows":91},"Beni-Suef University",[4],296,false,67,38,67050,43,179,[14,17,20,22,25,27,30,32],{"name":15,"count":16},"IVF",8,{"name":18,"count":19},"Breast Cancer",5,{"name":21,"count":19},"Pain",{"name":23,"count":24},"Ureteral Calculi",4,{"name":26,"count":24},"Chronic Hepatitis C Virus Infection",{"name":28,"count":29},"Patient Satisfaction",3,{"name":31,"count":29},"Covid19",{"name":33,"count":29},"Educational Problems",[35,40,45,50,55,60,65,70,75,80],{"nctId":36,"briefTitle":37,"date":38,"intervention":39},"NCT06816342","Assessment of Emergency Spacers Versus Traditional Spacers for Delivery of Aerosolized Drugs","2025-02-10","Ventoline® Evohaler® 100 µg\u002Finhalation pMDI alone",{"nctId":41,"briefTitle":42,"date":43,"intervention":44},"NCT06894472","A Comparative Study of EMG Biofeedback and Pharmacotherapy for the Treatment of Masticatory Muscle Hyperactivity in Bruxism Patients","2025-04-26","Pharmacotherapy",{"nctId":46,"briefTitle":47,"date":48,"intervention":49},"NCT06893835","Comparative Study of Clinical Outcomes and Safety Between Colistin and Tigecycline","2025-05-30","Colistimethate Sodium",{"nctId":51,"briefTitle":52,"date":53,"intervention":54},"NCT06785337","\"The Effect of Inhaled Nitroglycerin for COPD Patients","2025-10-01","Inhaled nitroglycerin",{"nctId":56,"briefTitle":57,"date":58,"intervention":59},"NCT06350773","Phosphodiesterase Type 5 Inhibitors in Patients With Group 2 Pulmonary Hypertension","2025-12-30","tadalafil 20 mg then 40 mg if tolerated",{"nctId":61,"briefTitle":62,"date":63,"intervention":64},"NCT07256262","Effect of Functional Magnetic Therapy on Constipation Predominant- Irritable Bowel Syndrome (IBS-C)","2026-01-28","Conventional pharmacological therapy",{"nctId":66,"briefTitle":67,"date":68,"intervention":69},"NCT07364578","Probiotic Supplements in Osteoarthritis","2026-02-15","Probiotic Formula",{"nctId":71,"briefTitle":72,"date":73,"intervention":74},"NCT07499817","Effect of Pentoxyfilline on Endometrial Thickness and Frozen Embryo Transfer Outcomes","2026-04-01","pentoxifylline 400 mg",{"nctId":76,"briefTitle":77,"date":78,"intervention":79},"NCT07499804","Effect of Tadalafil on Endometrial Thickness and Frozen Embryo Transfer Outcomes","2026-04-30","Tadalafil 5mg",{"nctId":81,"briefTitle":82,"date":78,"intervention":83},"NCT07474194","Preoperative Clindamycin Vaginal Cream Versus Vaginal Cleansing With Povidone-iodine on Postoperative Infections After Cesarean Section","Clindamycin vaginal cream",[85,86,87,88,89,90],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[92,118,136,159,177,209,227,245,263,281,299,317,335,353,371,395,413,438,461,479,499,522,549,567,609,645,672,690,708,734,752,805,828,854,872,890,912,939,961,989,1007,1025,1043,1061,1104,1152,1199,1235,1266,1303,1331,1355,1377,1395,1413,1438,1456,1483,1501,1519,1537,1564,1589,1615,1633,1660,1678,1701,1727,1745,1772,1790,1808,1826,1844,1867,1893,1911,1948,1970,1998,2026,2075,2110,2134,2152,2170,2188,2212,2230,2248,2274,2298,2316,2334,2364,2382,2400,2418,2436,2454,2472,2496,2520,2546,2564,2591,2609,2632,2650,2668,2686,2704,2722,2748,2766,2792,2817,2835,2853,2871,2889,2907,2925,2943,2961,2979,2997,3015,3033,3051,3077,3095,3113,3140,3158,3191,3215,3240,3258,3284,3302,3320,3342,3369,3392,3410,3434,3459,3477,3502,3525,3547,3571,3597,3615,3633,3656,3680,3704,3732,3750,3774,3800,3824,3850,3882,3918,3952,3980,4012,4036,4059,4077,4103,4126,4150,4168,4191,4216,4234,4258,4276,4294,4320,4344,4370,4388,4406,4424,4448],{"intervention":49,"totalTrials":93,"cells":94},1,{"EARLY_PHASE1":95,"PHASE1":98,"PHASE2":100,"PHASE3":102,"PHASE4":104,"NA":116},{"trials":96,"activeCount":97},[],0,{"trials":99,"activeCount":97},[],{"trials":101,"activeCount":97},[],{"trials":103,"activeCount":97},[],{"trials":105,"activeCount":93,"soonestReadout":48},[106],{"nctId":46,"briefTitle":47,"status":107,"phases":108,"primaryCompletion":48,"completion":109,"start":110,"enrollment":111,"conditions":112,"interventions":114},"ACTIVE_NOT_RECRUITING",[89],"2025-06-30","2024-12-01",132,[113],"Infection in ICU",[49,115],"Tigecycline",{"trials":117,"activeCount":97},[],{"intervention":115,"totalTrials":93,"cells":119},{"EARLY_PHASE1":120,"PHASE1":122,"PHASE2":124,"PHASE3":126,"PHASE4":128,"NA":134},{"trials":121,"activeCount":97},[],{"trials":123,"activeCount":97},[],{"trials":125,"activeCount":97},[],{"trials":127,"activeCount":97},[],{"trials":129,"activeCount":93,"soonestReadout":48},[130],{"nctId":46,"briefTitle":47,"status":107,"phases":131,"primaryCompletion":48,"completion":109,"start":110,"enrollment":111,"conditions":132,"interventions":133},[89],[113],[49,115],{"trials":135,"activeCount":97},[],{"intervention":79,"totalTrials":93,"cells":137},{"EARLY_PHASE1":138,"PHASE1":140,"PHASE2":142,"PHASE3":144,"PHASE4":146,"NA":157},{"trials":139,"activeCount":97},[],{"trials":141,"activeCount":97},[],{"trials":143,"activeCount":97},[],{"trials":145,"activeCount":97},[],{"trials":147,"activeCount":93,"soonestReadout":78},[148],{"nctId":76,"briefTitle":77,"status":149,"phases":150,"primaryCompletion":78,"completion":78,"start":151,"enrollment":152,"conditions":153,"interventions":155},"RECRUITING",[89],"2023-10-01",100,[15,154],"Infertility, Female",[79,156],"estradiol valerate 2 mg",{"trials":158,"activeCount":97},[],{"intervention":156,"totalTrials":93,"cells":160},{"EARLY_PHASE1":161,"PHASE1":163,"PHASE2":165,"PHASE3":167,"PHASE4":169,"NA":175},{"trials":162,"activeCount":97},[],{"trials":164,"activeCount":97},[],{"trials":166,"activeCount":97},[],{"trials":168,"activeCount":97},[],{"trials":170,"activeCount":93,"soonestReadout":78},[171],{"nctId":76,"briefTitle":77,"status":149,"phases":172,"primaryCompletion":78,"completion":78,"start":151,"enrollment":152,"conditions":173,"interventions":174},[89],[15,154],[79,156],{"trials":176,"activeCount":97},[],{"intervention":39,"totalTrials":93,"cells":178},{"EARLY_PHASE1":179,"PHASE1":181,"PHASE2":183,"PHASE3":185,"PHASE4":187,"NA":207},{"trials":180,"activeCount":97},[],{"trials":182,"activeCount":97},[],{"trials":184,"activeCount":97},[],{"trials":186,"activeCount":97},[],{"trials":188,"activeCount":93,"soonestReadout":38},[189],{"nctId":36,"briefTitle":37,"status":149,"phases":190,"primaryCompletion":38,"completion":38,"start":191,"enrollment":192,"conditions":193,"interventions":197},[89],"2024-11-01",120,[194,195,196],"Asthmatic Patients","MDI","Aerosol Generating Procedure",[39,198,199,200,201,202,203,204,205,206],"Ventoline® Evohaler® 100 µg\u002Finhalation pMDI connected to Able spacer","Ventoline® Evohaler® 100 µg\u002Finhalation pMDI connectec to Tips-Haler spacer","Ventoline® Evohaler® 100 µg\u002Finhalation pMDI connected to Aerochamber plus flow vu valved holding chamber","Ventoline® Evohaler® 100 µg\u002Finhalation pMDI connected to Atomizer chamber spacer","Ventoline® Evohaler® 100 µg\u002Finhalation pMDI connected to plastic juice cup spacer","Ventoline® Evohaler® 100 µg\u002Finhalation pMDI connected to the DispozABLE spacer","Ventoline® Evohaler® 100 µg\u002Finhalation pMDI connected to the Lite-Aire collapsible valved holding chamber spacer","Ventoline® Evohaler® 100 µg\u002Finhalation pMDI connected to the MDI package","Ventoline® Evohaler® 100 µg\u002Finhalation pMDI connected to the hand-made paper sheet spacer",{"trials":208,"activeCount":97},[],{"intervention":198,"totalTrials":93,"cells":210},{"EARLY_PHASE1":211,"PHASE1":213,"PHASE2":215,"PHASE3":217,"PHASE4":219,"NA":225},{"trials":212,"activeCount":97},[],{"trials":214,"activeCount":97},[],{"trials":216,"activeCount":97},[],{"trials":218,"activeCount":97},[],{"trials":220,"activeCount":93,"soonestReadout":38},[221],{"nctId":36,"briefTitle":37,"status":149,"phases":222,"primaryCompletion":38,"completion":38,"start":191,"enrollment":192,"conditions":223,"interventions":224},[89],[194,195,196],[39,198,199,200,201,202,203,204,205,206],{"trials":226,"activeCount":97},[],{"intervention":199,"totalTrials":93,"cells":228},{"EARLY_PHASE1":229,"PHASE1":231,"PHASE2":233,"PHASE3":235,"PHASE4":237,"NA":243},{"trials":230,"activeCount":97},[],{"trials":232,"activeCount":97},[],{"trials":234,"activeCount":97},[],{"trials":236,"activeCount":97},[],{"trials":238,"activeCount":93,"soonestReadout":38},[239],{"nctId":36,"briefTitle":37,"status":149,"phases":240,"primaryCompletion":38,"completion":38,"start":191,"enrollment":192,"conditions":241,"interventions":242},[89],[194,195,196],[39,198,199,200,201,202,203,204,205,206],{"trials":244,"activeCount":97},[],{"intervention":200,"totalTrials":93,"cells":246},{"EARLY_PHASE1":247,"PHASE1":249,"PHASE2":251,"PHASE3":253,"PHASE4":255,"NA":261},{"trials":248,"activeCount":97},[],{"trials":250,"activeCount":97},[],{"trials":252,"activeCount":97},[],{"trials":254,"activeCount":97},[],{"trials":256,"activeCount":93,"soonestReadout":38},[257],{"nctId":36,"briefTitle":37,"status":149,"phases":258,"primaryCompletion":38,"completion":38,"start":191,"enrollment":192,"conditions":259,"interventions":260},[89],[194,195,196],[39,198,199,200,201,202,203,204,205,206],{"trials":262,"activeCount":97},[],{"intervention":201,"totalTrials":93,"cells":264},{"EARLY_PHASE1":265,"PHASE1":267,"PHASE2":269,"PHASE3":271,"PHASE4":273,"NA":279},{"trials":266,"activeCount":97},[],{"trials":268,"activeCount":97},[],{"trials":270,"activeCount":97},[],{"trials":272,"activeCount":97},[],{"trials":274,"activeCount":93,"soonestReadout":38},[275],{"nctId":36,"briefTitle":37,"status":149,"phases":276,"primaryCompletion":38,"completion":38,"start":191,"enrollment":192,"conditions":277,"interventions":278},[89],[194,195,196],[39,198,199,200,201,202,203,204,205,206],{"trials":280,"activeCount":97},[],{"intervention":202,"totalTrials":93,"cells":282},{"EARLY_PHASE1":283,"PHASE1":285,"PHASE2":287,"PHASE3":289,"PHASE4":291,"NA":297},{"trials":284,"activeCount":97},[],{"trials":286,"activeCount":97},[],{"trials":288,"activeCount":97},[],{"trials":290,"activeCount":97},[],{"trials":292,"activeCount":93,"soonestReadout":38},[293],{"nctId":36,"briefTitle":37,"status":149,"phases":294,"primaryCompletion":38,"completion":38,"start":191,"enrollment":192,"conditions":295,"interventions":296},[89],[194,195,196],[39,198,199,200,201,202,203,204,205,206],{"trials":298,"activeCount":97},[],{"intervention":203,"totalTrials":93,"cells":300},{"EARLY_PHASE1":301,"PHASE1":303,"PHASE2":305,"PHASE3":307,"PHASE4":309,"NA":315},{"trials":302,"activeCount":97},[],{"trials":304,"activeCount":97},[],{"trials":306,"activeCount":97},[],{"trials":308,"activeCount":97},[],{"trials":310,"activeCount":93,"soonestReadout":38},[311],{"nctId":36,"briefTitle":37,"status":149,"phases":312,"primaryCompletion":38,"completion":38,"start":191,"enrollment":192,"conditions":313,"interventions":314},[89],[194,195,196],[39,198,199,200,201,202,203,204,205,206],{"trials":316,"activeCount":97},[],{"intervention":204,"totalTrials":93,"cells":318},{"EARLY_PHASE1":319,"PHASE1":321,"PHASE2":323,"PHASE3":325,"PHASE4":327,"NA":333},{"trials":320,"activeCount":97},[],{"trials":322,"activeCount":97},[],{"trials":324,"activeCount":97},[],{"trials":326,"activeCount":97},[],{"trials":328,"activeCount":93,"soonestReadout":38},[329],{"nctId":36,"briefTitle":37,"status":149,"phases":330,"primaryCompletion":38,"completion":38,"start":191,"enrollment":192,"conditions":331,"interventions":332},[89],[194,195,196],[39,198,199,200,201,202,203,204,205,206],{"trials":334,"activeCount":97},[],{"intervention":205,"totalTrials":93,"cells":336},{"EARLY_PHASE1":337,"PHASE1":339,"PHASE2":341,"PHASE3":343,"PHASE4":345,"NA":351},{"trials":338,"activeCount":97},[],{"trials":340,"activeCount":97},[],{"trials":342,"activeCount":97},[],{"trials":344,"activeCount":97},[],{"trials":346,"activeCount":93,"soonestReadout":38},[347],{"nctId":36,"briefTitle":37,"status":149,"phases":348,"primaryCompletion":38,"completion":38,"start":191,"enrollment":192,"conditions":349,"interventions":350},[89],[194,195,196],[39,198,199,200,201,202,203,204,205,206],{"trials":352,"activeCount":97},[],{"intervention":206,"totalTrials":93,"cells":354},{"EARLY_PHASE1":355,"PHASE1":357,"PHASE2":359,"PHASE3":361,"PHASE4":363,"NA":369},{"trials":356,"activeCount":97},[],{"trials":358,"activeCount":97},[],{"trials":360,"activeCount":97},[],{"trials":362,"activeCount":97},[],{"trials":364,"activeCount":93,"soonestReadout":38},[365],{"nctId":36,"briefTitle":37,"status":149,"phases":366,"primaryCompletion":38,"completion":38,"start":191,"enrollment":192,"conditions":367,"interventions":368},[89],[194,195,196],[39,198,199,200,201,202,203,204,205,206],{"trials":370,"activeCount":97},[],{"intervention":83,"totalTrials":93,"cells":372},{"EARLY_PHASE1":373,"PHASE1":375,"PHASE2":377,"PHASE3":379,"PHASE4":381,"NA":393},{"trials":374,"activeCount":97},[],{"trials":376,"activeCount":97},[],{"trials":378,"activeCount":97},[],{"trials":380,"activeCount":97},[],{"trials":382,"activeCount":93,"soonestReadout":78},[383],{"nctId":81,"briefTitle":82,"status":149,"phases":384,"primaryCompletion":78,"completion":385,"start":386,"enrollment":387,"conditions":388,"interventions":391},[89],"2026-05-01","2025-09-20",150,[389,390],"Infection Control \u002F Methods","Surgical Site Infection (SSI)",[83,392],"Vaginal preparation with povidone- iodide solution 10 %",{"trials":394,"activeCount":97},[],{"intervention":392,"totalTrials":93,"cells":396},{"EARLY_PHASE1":397,"PHASE1":399,"PHASE2":401,"PHASE3":403,"PHASE4":405,"NA":411},{"trials":398,"activeCount":97},[],{"trials":400,"activeCount":97},[],{"trials":402,"activeCount":97},[],{"trials":404,"activeCount":97},[],{"trials":406,"activeCount":93,"soonestReadout":78},[407],{"nctId":81,"briefTitle":82,"status":149,"phases":408,"primaryCompletion":78,"completion":385,"start":386,"enrollment":387,"conditions":409,"interventions":410},[89],[389,390],[83,392],{"trials":412,"activeCount":97},[],{"intervention":414,"totalTrials":93,"cells":415},"diosmin\u002Fhesperdin",{"EARLY_PHASE1":416,"PHASE1":418,"PHASE2":420,"PHASE3":422,"PHASE4":424,"NA":436},{"trials":417,"activeCount":97},[],{"trials":419,"activeCount":97},[],{"trials":421,"activeCount":97},[],{"trials":423,"activeCount":97},[],{"trials":425,"activeCount":93,"soonestReadout":430},[426],{"nctId":427,"briefTitle":428,"status":149,"phases":429,"primaryCompletion":430,"completion":431,"start":432,"enrollment":152,"conditions":433,"interventions":435},"NCT07598214","Effect of Diosmin\u002FHesperidin Combination on Platinum Compounds-Induced Nephropathy in Cancer Patients",[89],"2026-11-03","2026-12-03","2025-02-03",[434],"Cancer Patients",[414],{"trials":437,"activeCount":97},[],{"intervention":69,"totalTrials":93,"cells":439},{"EARLY_PHASE1":440,"PHASE1":442,"PHASE2":444,"PHASE3":446,"PHASE4":457,"NA":459},{"trials":441,"activeCount":97},[],{"trials":443,"activeCount":97},[],{"trials":445,"activeCount":97},[],{"trials":447,"activeCount":93,"soonestReadout":68},[448],{"nctId":66,"briefTitle":67,"status":149,"phases":449,"primaryCompletion":68,"completion":450,"start":451,"enrollment":452,"conditions":453,"interventions":455},[88],"2026-03-01","2025-02-15",146,[454],"Osteoarthritis, Knee",[69,456],"Control",{"trials":458,"activeCount":97},[],{"trials":460,"activeCount":97},[],{"intervention":456,"totalTrials":93,"cells":462},{"EARLY_PHASE1":463,"PHASE1":465,"PHASE2":467,"PHASE3":469,"PHASE4":475,"NA":477},{"trials":464,"activeCount":97},[],{"trials":466,"activeCount":97},[],{"trials":468,"activeCount":97},[],{"trials":470,"activeCount":93,"soonestReadout":68},[471],{"nctId":66,"briefTitle":67,"status":149,"phases":472,"primaryCompletion":68,"completion":450,"start":451,"enrollment":452,"conditions":473,"interventions":474},[88],[454],[69,456],{"trials":476,"activeCount":97},[],{"trials":478,"activeCount":97},[],{"intervention":74,"totalTrials":93,"cells":480},{"EARLY_PHASE1":481,"PHASE1":483,"PHASE2":485,"PHASE3":487,"PHASE4":495,"NA":497},{"trials":482,"activeCount":97},[],{"trials":484,"activeCount":97},[],{"trials":486,"activeCount":97},[],{"trials":488,"activeCount":93,"soonestReadout":73},[489],{"nctId":71,"briefTitle":72,"status":149,"phases":490,"primaryCompletion":73,"completion":78,"start":151,"enrollment":152,"conditions":491,"interventions":494},[88],[492,15,493],"Embryo Transfer","Infertility",[74],{"trials":496,"activeCount":97},[],{"trials":498,"activeCount":97},[],{"intervention":54,"totalTrials":93,"cells":500},{"EARLY_PHASE1":501,"PHASE1":503,"PHASE2":505,"PHASE3":507,"PHASE4":518,"NA":520},{"trials":502,"activeCount":97},[],{"trials":504,"activeCount":97},[],{"trials":506,"activeCount":97},[],{"trials":508,"activeCount":93,"soonestReadout":53},[509],{"nctId":51,"briefTitle":52,"status":149,"phases":510,"primaryCompletion":53,"completion":511,"start":512,"enrollment":513,"conditions":514,"interventions":517},[87,88],"2025-12-01","2025-02-01",40,[515,516],"COPD","COPD III\u002FIV",[54],{"trials":519,"activeCount":97},[],{"trials":521,"activeCount":97},[],{"intervention":523,"totalTrials":93,"cells":524},"Somatropin (4IU for 1 month) plus, folic acid 400 mcg per day.",{"EARLY_PHASE1":525,"PHASE1":527,"PHASE2":529,"PHASE3":531,"PHASE4":545,"NA":547},{"trials":526,"activeCount":97},[],{"trials":528,"activeCount":97},[],{"trials":530,"activeCount":97},[],{"trials":532,"activeCount":93,"soonestReadout":537},[533],{"nctId":534,"briefTitle":535,"status":149,"phases":536,"primaryCompletion":537,"completion":538,"start":539,"enrollment":540,"conditions":541,"interventions":543},"NCT07323329","Growth Hormone and Dehydroepiandrosterone Role in Vitro Fertilization",[87,88],"2026-10-15","2026-11-12","2025-10-10",165,[493,542],"Infertility (IVF Patients)",[523,544],"DHEA plus folic acid 400mcg per day",{"trials":546,"activeCount":97},[],{"trials":548,"activeCount":97},[],{"intervention":544,"totalTrials":93,"cells":550},{"EARLY_PHASE1":551,"PHASE1":553,"PHASE2":555,"PHASE3":557,"PHASE4":563,"NA":565},{"trials":552,"activeCount":97},[],{"trials":554,"activeCount":97},[],{"trials":556,"activeCount":97},[],{"trials":558,"activeCount":93,"soonestReadout":537},[559],{"nctId":534,"briefTitle":535,"status":149,"phases":560,"primaryCompletion":537,"completion":538,"start":539,"enrollment":540,"conditions":561,"interventions":562},[87,88],[493,542],[523,544],{"trials":564,"activeCount":97},[],{"trials":566,"activeCount":97},[],{"intervention":568,"totalTrials":569,"cells":570},"Melatonin",2,{"EARLY_PHASE1":571,"PHASE1":573,"PHASE2":575,"PHASE3":590,"PHASE4":605,"NA":607},{"trials":572,"activeCount":97},[],{"trials":574,"activeCount":97},[],{"trials":576,"activeCount":93,"soonestReadout":581},[577],{"nctId":578,"briefTitle":579,"status":149,"phases":580,"primaryCompletion":581,"completion":582,"start":583,"enrollment":584,"conditions":585,"interventions":588},"NCT07617922","Melatonin and Solifenacin for Double-J Ureteral Stent Symptoms",[87],"2027-04","2027-05","2026-05-07",189,[586,23,587],"Ureteral Stent-Related Symptoms","Lower Urinary Tract Symptoms",[589,568],"Solifenacin",{"trials":591,"activeCount":97},[592],{"nctId":593,"briefTitle":594,"status":595,"phases":596,"primaryCompletion":597,"completion":597,"start":598,"enrollment":599,"conditions":600,"interventions":601},"NCT06405204","of Myo-inositol, Melatonin and Co-enzyme q10 on Ovarian Reserve","UNKNOWN",[88],"2024-12-30","2024-06-30",200,[15],[602,603,568,604],"Myoinositol","Co-Enzyme Q10","Folic acid",{"trials":606,"activeCount":97},[],{"trials":608,"activeCount":97},[],{"intervention":610,"totalTrials":569,"cells":611},"Aminophylline",{"EARLY_PHASE1":612,"PHASE1":614,"PHASE2":626,"PHASE3":639,"PHASE4":641,"NA":643},{"trials":613,"activeCount":97},[],{"trials":615,"activeCount":97},[616],{"nctId":617,"briefTitle":618,"status":595,"phases":619,"primaryCompletion":620,"completion":620,"start":621,"enrollment":622,"conditions":623,"interventions":625},"NCT04151381","The Effect of Preoperative Aminophylline",[86],"2019-12","2019-11",45,[624],"Recovery From Anesthesia",[610],{"trials":627,"activeCount":93,"soonestReadout":581},[628],{"nctId":629,"briefTitle":630,"status":149,"phases":631,"primaryCompletion":581,"completion":582,"start":632,"enrollment":633,"conditions":634,"interventions":637},"NCT07617896","Intravesical Aminophylline to Facilitate Ureteroscopic Access in Children With Distal Ureteral Stones.",[87],"2026-05-09",60,[635,636,23],"Pediatric Urolithiasis","Distal Ureteral Stone",[610,638],"Normal Saline Placebo",{"trials":640,"activeCount":97},[],{"trials":642,"activeCount":97},[],{"trials":644,"activeCount":97},[],{"intervention":646,"totalTrials":93,"cells":647},"Intravesical Aminophylline",{"EARLY_PHASE1":648,"PHASE1":650,"PHASE2":652,"PHASE3":666,"PHASE4":668,"NA":670},{"trials":649,"activeCount":97},[],{"trials":651,"activeCount":97},[],{"trials":653,"activeCount":93,"soonestReadout":658},[654],{"nctId":655,"briefTitle":656,"status":149,"phases":657,"primaryCompletion":658,"completion":581,"start":659,"enrollment":660,"conditions":661,"interventions":665},"NCT07617948","Intravesical Aminophylline for Urgent Ureteral Stenting in Acute Calculous Anuria",[87],"2027-03","2026-04-08",72,[662,23,663,664],"Acute Calculous Anuria","Obstructive Uropathy","Acute Kidney Injury",[646],{"trials":667,"activeCount":97},[],{"trials":669,"activeCount":97},[],{"trials":671,"activeCount":97},[],{"intervention":589,"totalTrials":93,"cells":673},{"EARLY_PHASE1":674,"PHASE1":676,"PHASE2":678,"PHASE3":684,"PHASE4":686,"NA":688},{"trials":675,"activeCount":97},[],{"trials":677,"activeCount":97},[],{"trials":679,"activeCount":93,"soonestReadout":581},[680],{"nctId":578,"briefTitle":579,"status":149,"phases":681,"primaryCompletion":581,"completion":582,"start":583,"enrollment":584,"conditions":682,"interventions":683},[87],[586,23,587],[589,568],{"trials":685,"activeCount":97},[],{"trials":687,"activeCount":97},[],{"trials":689,"activeCount":97},[],{"intervention":638,"totalTrials":93,"cells":691},{"EARLY_PHASE1":692,"PHASE1":694,"PHASE2":696,"PHASE3":702,"PHASE4":704,"NA":706},{"trials":693,"activeCount":97},[],{"trials":695,"activeCount":97},[],{"trials":697,"activeCount":93,"soonestReadout":581},[698],{"nctId":629,"briefTitle":630,"status":149,"phases":699,"primaryCompletion":581,"completion":582,"start":632,"enrollment":633,"conditions":700,"interventions":701},[87],[635,636,23],[610,638],{"trials":703,"activeCount":97},[],{"trials":705,"activeCount":97},[],{"trials":707,"activeCount":97},[],{"intervention":709,"totalTrials":93,"cells":710},"L-Citrulline",{"EARLY_PHASE1":711,"PHASE1":713,"PHASE2":715,"PHASE3":728,"PHASE4":730,"NA":732},{"trials":712,"activeCount":97},[],{"trials":714,"activeCount":97},[],{"trials":716,"activeCount":93,"soonestReadout":721},[717],{"nctId":718,"briefTitle":719,"status":149,"phases":720,"primaryCompletion":721,"completion":722,"start":723,"enrollment":192,"conditions":724,"interventions":726},"NCT07617909","L-Citrulline Versus Tamsulosin for Medical Expulsive Therapy of Distal Ureteral Stones",[87],"2026-10","2026-11","2026-05-06",[636,725,23],"Urolithiasis",[709,727],"Tamsulosin",{"trials":729,"activeCount":97},[],{"trials":731,"activeCount":97},[],{"trials":733,"activeCount":97},[],{"intervention":727,"totalTrials":93,"cells":735},{"EARLY_PHASE1":736,"PHASE1":738,"PHASE2":740,"PHASE3":746,"PHASE4":748,"NA":750},{"trials":737,"activeCount":97},[],{"trials":739,"activeCount":97},[],{"trials":741,"activeCount":93,"soonestReadout":721},[742],{"nctId":718,"briefTitle":719,"status":149,"phases":743,"primaryCompletion":721,"completion":722,"start":723,"enrollment":192,"conditions":744,"interventions":745},[87],[636,725,23],[709,727],{"trials":747,"activeCount":97},[],{"trials":749,"activeCount":97},[],{"trials":751,"activeCount":97},[],{"intervention":753,"totalTrials":29,"cells":754},"Control group",{"EARLY_PHASE1":755,"PHASE1":757,"PHASE2":759,"PHASE3":761,"PHASE4":763,"NA":777},{"trials":756,"activeCount":97},[],{"trials":758,"activeCount":97},[],{"trials":760,"activeCount":97},[],{"trials":762,"activeCount":97},[],{"trials":764,"activeCount":97},[765],{"nctId":766,"briefTitle":767,"status":595,"phases":768,"primaryCompletion":598,"completion":769,"start":770,"enrollment":771,"conditions":772,"interventions":774},"NCT06164535","The Effects of DPPIs on Cognitive Function of Diabetic Patients",[89],"2024-07-15","2023-12-30",105,[773],"Cognitive Impairment",[753,775,776],"DPP-4 inhibitor group","DPP-4 inhibitor + metformin group",{"trials":778,"activeCount":93,"soonestReadout":796},[779,792],{"nctId":780,"briefTitle":781,"status":782,"phases":783,"primaryCompletion":784,"completion":785,"start":786,"enrollment":787,"conditions":788,"interventions":790},"NCT06738108","EKOS in Patients With Pulmonary Embolism (PE)","COMPLETED",[],"2024-12-20","2025-01-08","2024-12-13",104,[789],"Pulmonary Embolism",[791,753],"ECOS",{"nctId":793,"briefTitle":794,"status":149,"phases":795,"primaryCompletion":796,"completion":797,"start":798,"enrollment":799,"conditions":800,"interventions":802},"NCT07244770","The Effects of Some Antihyperglycemic Drugs on Cognitive Function and Risk of Depression of Diabetic Patients",[],"2026-06-01","2026-12-30","2025-01-01",300,[801],"MCI",[803,804,753],"SGLT2 Is+METFORMIN","DPP4 Is+metformin",{"intervention":44,"totalTrials":93,"cells":806},{"EARLY_PHASE1":807,"PHASE1":809,"PHASE2":811,"PHASE3":813,"PHASE4":815,"NA":817},{"trials":808,"activeCount":97},[],{"trials":810,"activeCount":97},[],{"trials":812,"activeCount":97},[],{"trials":814,"activeCount":97},[],{"trials":816,"activeCount":97},[],{"trials":818,"activeCount":93,"soonestReadout":43},[819],{"nctId":41,"briefTitle":42,"status":820,"phases":821,"primaryCompletion":43,"completion":822,"start":823,"enrollment":824,"conditions":825,"interventions":827},"NOT_YET_RECRUITING",[90],"2025-05-01","2025-03-26",30,[826],"Bruxism",[44],{"intervention":829,"totalTrials":93,"cells":830},"Metformin monotherapy",{"EARLY_PHASE1":831,"PHASE1":833,"PHASE2":835,"PHASE3":837,"PHASE4":839,"NA":841},{"trials":832,"activeCount":97},[],{"trials":834,"activeCount":97},[],{"trials":836,"activeCount":97},[],{"trials":838,"activeCount":97},[],{"trials":840,"activeCount":97},[],{"trials":842,"activeCount":93,"soonestReadout":431},[843],{"nctId":844,"briefTitle":845,"status":107,"phases":846,"primaryCompletion":431,"completion":847,"start":848,"enrollment":387,"conditions":849,"interventions":851},"NCT07604779","Enhancing PCOS Management for Better Outcomes of Intracytoplasmic Sperm Injection",[90],"2027-03-03","2026-05-17",[850],"Polycystic Ovarian Syndrome (PCOS)",[829,852,853],"Myoinositol and metformin","pioglitazone and metformin",{"intervention":852,"totalTrials":93,"cells":855},{"EARLY_PHASE1":856,"PHASE1":858,"PHASE2":860,"PHASE3":862,"PHASE4":864,"NA":866},{"trials":857,"activeCount":97},[],{"trials":859,"activeCount":97},[],{"trials":861,"activeCount":97},[],{"trials":863,"activeCount":97},[],{"trials":865,"activeCount":97},[],{"trials":867,"activeCount":93,"soonestReadout":431},[868],{"nctId":844,"briefTitle":845,"status":107,"phases":869,"primaryCompletion":431,"completion":847,"start":848,"enrollment":387,"conditions":870,"interventions":871},[90],[850],[829,852,853],{"intervention":853,"totalTrials":93,"cells":873},{"EARLY_PHASE1":874,"PHASE1":876,"PHASE2":878,"PHASE3":880,"PHASE4":882,"NA":884},{"trials":875,"activeCount":97},[],{"trials":877,"activeCount":97},[],{"trials":879,"activeCount":97},[],{"trials":881,"activeCount":97},[],{"trials":883,"activeCount":97},[],{"trials":885,"activeCount":93,"soonestReadout":431},[886],{"nctId":844,"briefTitle":845,"status":107,"phases":887,"primaryCompletion":431,"completion":847,"start":848,"enrollment":387,"conditions":888,"interventions":889},[90],[850],[829,852,853],{"intervention":59,"totalTrials":93,"cells":891},{"EARLY_PHASE1":892,"PHASE1":894,"PHASE2":896,"PHASE3":898,"PHASE4":900,"NA":902},{"trials":893,"activeCount":97},[],{"trials":895,"activeCount":97},[],{"trials":897,"activeCount":97},[],{"trials":899,"activeCount":97},[],{"trials":901,"activeCount":97},[],{"trials":903,"activeCount":93,"soonestReadout":58},[904],{"nctId":56,"briefTitle":57,"status":107,"phases":905,"primaryCompletion":58,"completion":906,"start":907,"enrollment":908,"conditions":909,"interventions":911},[90],"2026-06","2023-06-10",48,[910],"Group 2 Pulmonary Hypertension",[59],{"intervention":913,"totalTrials":93,"cells":914},"OnabotulinumtoxinA",{"EARLY_PHASE1":915,"PHASE1":917,"PHASE2":919,"PHASE3":921,"PHASE4":923,"NA":925},{"trials":916,"activeCount":97},[],{"trials":918,"activeCount":97},[],{"trials":920,"activeCount":97},[],{"trials":922,"activeCount":97},[],{"trials":924,"activeCount":97},[],{"trials":926,"activeCount":93,"soonestReadout":721},[927],{"nctId":928,"briefTitle":929,"status":820,"phases":930,"primaryCompletion":721,"completion":931,"start":932,"enrollment":933,"conditions":934,"interventions":938},"NCT07535723","Botulinum Toxin and\u002For Greater Occipital Nerve Block for Patients With Chronic Migraine",[90],"2026-12","2026-04",90,[935,913,936,937],"Chronic Migraine Headache","Greater Occipital Nerve Block","Combination Therapy",[913],{"intervention":64,"totalTrials":93,"cells":940},{"EARLY_PHASE1":941,"PHASE1":943,"PHASE2":945,"PHASE3":947,"PHASE4":949,"NA":951},{"trials":942,"activeCount":97},[],{"trials":944,"activeCount":97},[],{"trials":946,"activeCount":97},[],{"trials":948,"activeCount":97},[],{"trials":950,"activeCount":97},[],{"trials":952,"activeCount":93,"soonestReadout":63},[953],{"nctId":61,"briefTitle":62,"status":820,"phases":954,"primaryCompletion":63,"completion":955,"start":956,"enrollment":957,"conditions":958,"interventions":960},[90],"2026-02-14","2025-11-28",50,[959],"Irritable Bowel Syndrome",[64],{"intervention":962,"totalTrials":93,"cells":963},"GLP-1 analog",{"EARLY_PHASE1":964,"PHASE1":966,"PHASE2":968,"PHASE3":970,"PHASE4":972,"NA":974},{"trials":965,"activeCount":97},[],{"trials":967,"activeCount":97},[],{"trials":969,"activeCount":97},[],{"trials":971,"activeCount":97},[],{"trials":973,"activeCount":97},[],{"trials":975,"activeCount":93,"soonestReadout":980},[976],{"nctId":977,"briefTitle":978,"status":820,"phases":979,"primaryCompletion":980,"completion":981,"start":982,"enrollment":983,"conditions":984,"interventions":986},"NCT07360457","GLP1 Analogues and the Risk of Osteoarthritis",[],"2026-12-01","2027-03-01","2026-02-01",390,[985],"Osteoarthritis",[962,987,988],"SGLT2 inhibitor","Antidiabetic",{"intervention":987,"totalTrials":93,"cells":990},{"EARLY_PHASE1":991,"PHASE1":993,"PHASE2":995,"PHASE3":997,"PHASE4":999,"NA":1001},{"trials":992,"activeCount":97},[],{"trials":994,"activeCount":97},[],{"trials":996,"activeCount":97},[],{"trials":998,"activeCount":97},[],{"trials":1000,"activeCount":97},[],{"trials":1002,"activeCount":93,"soonestReadout":980},[1003],{"nctId":977,"briefTitle":978,"status":820,"phases":1004,"primaryCompletion":980,"completion":981,"start":982,"enrollment":983,"conditions":1005,"interventions":1006},[],[985],[962,987,988],{"intervention":988,"totalTrials":93,"cells":1008},{"EARLY_PHASE1":1009,"PHASE1":1011,"PHASE2":1013,"PHASE3":1015,"PHASE4":1017,"NA":1019},{"trials":1010,"activeCount":97},[],{"trials":1012,"activeCount":97},[],{"trials":1014,"activeCount":97},[],{"trials":1016,"activeCount":97},[],{"trials":1018,"activeCount":97},[],{"trials":1020,"activeCount":93,"soonestReadout":980},[1021],{"nctId":977,"briefTitle":978,"status":820,"phases":1022,"primaryCompletion":980,"completion":981,"start":982,"enrollment":983,"conditions":1023,"interventions":1024},[],[985],[962,987,988],{"intervention":803,"totalTrials":93,"cells":1026},{"EARLY_PHASE1":1027,"PHASE1":1029,"PHASE2":1031,"PHASE3":1033,"PHASE4":1035,"NA":1037},{"trials":1028,"activeCount":97},[],{"trials":1030,"activeCount":97},[],{"trials":1032,"activeCount":97},[],{"trials":1034,"activeCount":97},[],{"trials":1036,"activeCount":97},[],{"trials":1038,"activeCount":93,"soonestReadout":796},[1039],{"nctId":793,"briefTitle":794,"status":149,"phases":1040,"primaryCompletion":796,"completion":797,"start":798,"enrollment":799,"conditions":1041,"interventions":1042},[],[801],[803,804,753],{"intervention":804,"totalTrials":93,"cells":1044},{"EARLY_PHASE1":1045,"PHASE1":1047,"PHASE2":1049,"PHASE3":1051,"PHASE4":1053,"NA":1055},{"trials":1046,"activeCount":97},[],{"trials":1048,"activeCount":97},[],{"trials":1050,"activeCount":97},[],{"trials":1052,"activeCount":97},[],{"trials":1054,"activeCount":97},[],{"trials":1056,"activeCount":93,"soonestReadout":796},[1057],{"nctId":793,"briefTitle":794,"status":149,"phases":1058,"primaryCompletion":796,"completion":797,"start":798,"enrollment":799,"conditions":1059,"interventions":1060},[],[801],[803,804,753],{"intervention":1062,"totalTrials":29,"cells":1063},"Misoprostol",{"EARLY_PHASE1":1064,"PHASE1":1066,"PHASE2":1068,"PHASE3":1070,"PHASE4":1083,"NA":1102},{"trials":1065,"activeCount":97},[],{"trials":1067,"activeCount":97},[],{"trials":1069,"activeCount":97},[],{"trials":1071,"activeCount":97},[1072],{"nctId":1073,"briefTitle":1074,"status":782,"phases":1075,"primaryCompletion":1076,"completion":1077,"start":1078,"enrollment":933,"conditions":1079,"interventions":1081},"NCT05761418","Preoperative Vaginal Dinoprostone Versus Misoprostone in Abdominal Myomectomy",[88],"2023-02-15","2023-02-20","2018-03-01",[1080],"Myoma;Uterus",[1082,1062],"Dinoprostone",{"trials":1084,"activeCount":97},[1085,1095],{"nctId":1086,"briefTitle":1087,"status":595,"phases":1088,"primaryCompletion":1089,"completion":1089,"start":1090,"enrollment":599,"conditions":1091,"interventions":1093},"NCT02277067","Carbetocin Versus Misoprostol in High Risk Patients for Postpartum Hemorrhage After C.S.",[89],"2021-08","2014-10",[1092],"Postpartum Hemorrhage",[1094,1062],"Carbetocin",{"nctId":1096,"briefTitle":1097,"status":595,"phases":1098,"primaryCompletion":1099,"completion":1099,"start":1090,"enrollment":599,"conditions":1100,"interventions":1101},"NCT02277041","Carbetocin Versus Misoprostol in Cases With Placenta Previa After C.S.",[89],"2021-04",[1092],[1094,1062],{"trials":1103,"activeCount":97},[],{"intervention":1105,"totalTrials":29,"cells":1106},"Letrozole 2.5mg",{"EARLY_PHASE1":1107,"PHASE1":1109,"PHASE2":1111,"PHASE3":1113,"PHASE4":1133,"NA":1150},{"trials":1108,"activeCount":97},[],{"trials":1110,"activeCount":97},[],{"trials":1112,"activeCount":97},[],{"trials":1114,"activeCount":97},[1115,1125],{"nctId":1116,"briefTitle":1117,"status":595,"phases":1118,"primaryCompletion":1119,"completion":1119,"start":598,"enrollment":152,"conditions":1120,"interventions":1122},"NCT06405243","Myoinositol, L-arginine and Chromium With Letrozole for Ovulation Induction in Polycystic Ovarian Syndrome Patients",[88],"2024-12-31",[1121],"Polycystic Ovary Syndrome",[602,1123,1124,1105],"Chromium","l-arginine",{"nctId":1126,"briefTitle":1127,"status":782,"phases":1128,"primaryCompletion":1129,"completion":1129,"start":151,"enrollment":1130,"conditions":1131,"interventions":1132},"NCT06403488","Letrozole Dose Increments in PCOS Patients Resistant to Letrozole",[88],"2024-01-30",102,[1121],[1105],{"trials":1134,"activeCount":97},[1135],{"nctId":1136,"briefTitle":1137,"status":782,"phases":1138,"primaryCompletion":1139,"completion":1140,"start":1141,"enrollment":1142,"conditions":1143,"interventions":1145},"NCT07589075","Sodium-Glucose Co-Transporter-2 Inhibitors as Adjuvant Therapy With Letrozole in Induction of Ovulation",[89],"2024-07-01","2025-10-30","2023-10-20",500,[1144],"Induction of Ovulation",[1146,1147,1148,1149],"Metformin 1000 mg","Dapagliflozin 10 mg","Combined Dapagliflozin-Metformin 5\u002F1000mg","Letrozole 2.5Mg",{"trials":1151,"activeCount":97},[],{"intervention":1153,"totalTrials":29,"cells":1154},"Chemotherapy",{"EARLY_PHASE1":1155,"PHASE1":1157,"PHASE2":1159,"PHASE3":1182,"PHASE4":1184,"NA":1197},{"trials":1156,"activeCount":97},[],{"trials":1158,"activeCount":97},[],{"trials":1160,"activeCount":97},[1161,1172],{"nctId":1162,"briefTitle":1163,"status":595,"phases":1164,"primaryCompletion":1165,"completion":1166,"start":1167,"enrollment":1168,"conditions":1169,"interventions":1170},"NCT04559308","The Effect of Metformin on Breast Cancer Patients",[87],"2020-09-15","2020-10","2019-06-01",80,[18],[1171,1153],"Metformin",{"nctId":1173,"briefTitle":1174,"status":595,"phases":1175,"primaryCompletion":1176,"completion":191,"start":1177,"enrollment":1168,"conditions":1178,"interventions":1180},"NCT04536467","Prevention of Chemotherapy-Induced Ovarian Failure With Goserelin in Premenopausal Lymphoma Patients",[87],"2020-12-01","2019-03-01",[1179],"Premature Ovarian Failure",[1181,1153],"Goserelin",{"trials":1183,"activeCount":97},[],{"trials":1185,"activeCount":97},[1186],{"nctId":1187,"briefTitle":1188,"status":782,"phases":1189,"primaryCompletion":1190,"completion":1190,"start":1191,"enrollment":1192,"conditions":1193,"interventions":1195},"NCT05840068","IGF Level in Breast Cancer Patients Treated With Metformin",[89],"2021-07-31","2020-06-01",107,[1194],"Breast Cancer Female",[1196,1153],"MetFORMIN 500 Mg Oral",{"trials":1198,"activeCount":97},[],{"intervention":1200,"totalTrials":569,"cells":1201},"Propofol",{"EARLY_PHASE1":1202,"PHASE1":1204,"PHASE2":1206,"PHASE3":1208,"PHASE4":1210,"NA":1233},{"trials":1203,"activeCount":97},[],{"trials":1205,"activeCount":97},[],{"trials":1207,"activeCount":97},[],{"trials":1209,"activeCount":97},[],{"trials":1211,"activeCount":97},[1212,1223],{"nctId":1213,"briefTitle":1214,"status":595,"phases":1215,"primaryCompletion":822,"completion":822,"start":1216,"enrollment":1217,"conditions":1218,"interventions":1221},"NCT06369103","The Sedative Effects of Dexmedetomidine VS Propofol During Peribulbar Anesthesia in Patients Undergoing Vitrectomy Surgery",[89],"2024-05-01",420,[1219,1220],"Patient","Satisfaction",[1222,1200],"Dexmedetomidine",{"nctId":1224,"briefTitle":1225,"status":782,"phases":1226,"primaryCompletion":1227,"completion":1227,"start":1228,"enrollment":1168,"conditions":1229,"interventions":1232},"NCT04874545","Effect of Propfol Versus Sevoflurane on Auditory and Cognitive Function",[89],"2021-12-01","2021-06-01",[1230,1231],"Cognitive Dysfunction","Auditory Dysfunction, Central",[1200],{"trials":1234,"activeCount":97},[],{"intervention":1146,"totalTrials":569,"cells":1236},{"EARLY_PHASE1":1237,"PHASE1":1239,"PHASE2":1241,"PHASE3":1243,"PHASE4":1245,"NA":1264},{"trials":1238,"activeCount":97},[],{"trials":1240,"activeCount":97},[],{"trials":1242,"activeCount":97},[],{"trials":1244,"activeCount":97},[],{"trials":1246,"activeCount":97},[1247,1251],{"nctId":1136,"briefTitle":1137,"status":782,"phases":1248,"primaryCompletion":1139,"completion":1140,"start":1141,"enrollment":1142,"conditions":1249,"interventions":1250},[89],[1144],[1146,1147,1148,1149],{"nctId":1252,"briefTitle":1253,"status":782,"phases":1254,"primaryCompletion":1255,"completion":1256,"start":1257,"enrollment":633,"conditions":1258,"interventions":1260},"NCT04916093","Safety and Efficacy of Antidiabetic Drugs in Recently Diagnosed Patients With Type 2 Diabetes",[89],"2020-06-10","2020-12-15","2019-12-20",[1259],"Diabetes Mellitus, Type 2",[1261,1262,1263],"Vildagliptin 50 MG","Sitagliptin 100mg","MetFORMIN 1000 Mg Oral",{"trials":1265,"activeCount":97},[],{"intervention":1267,"totalTrials":569,"cells":1268},"Clomiphene Citrate 50mg",{"EARLY_PHASE1":1269,"PHASE1":1271,"PHASE2":1273,"PHASE3":1275,"PHASE4":1287,"NA":1301},{"trials":1270,"activeCount":97},[],{"trials":1272,"activeCount":97},[],{"trials":1274,"activeCount":97},[],{"trials":1276,"activeCount":97},[1277],{"nctId":1278,"briefTitle":1279,"status":782,"phases":1280,"primaryCompletion":1281,"completion":1281,"start":1282,"enrollment":1283,"conditions":1284,"interventions":1285},"NCT05846906","Effect of Oral Sildenafil Citrate on Improvement of Endometrial Thickness",[87,88],"2022-04-30","2021-10-01",130,[154],[1286,1267],"Sildenafil Citrate",{"trials":1288,"activeCount":97},[1289],{"nctId":1290,"briefTitle":1291,"status":782,"phases":1292,"primaryCompletion":1293,"completion":1293,"start":1294,"enrollment":1295,"conditions":1296,"interventions":1298},"NCT05753098","Effect of Sildenafil Citrate Compared to Estrogen as Adjuvant Therapy for Unexplained Infertility",[89],"2023-01-31","2021-01-15",148,[1297],"Subfertility, Female",[1299,1300,1267],"estrogen therapy","Sildenafil",{"trials":1302,"activeCount":97},[],{"intervention":1300,"totalTrials":569,"cells":1304},{"EARLY_PHASE1":1305,"PHASE1":1307,"PHASE2":1309,"PHASE3":1311,"PHASE4":1323,"NA":1329},{"trials":1306,"activeCount":97},[],{"trials":1308,"activeCount":97},[],{"trials":1310,"activeCount":97},[],{"trials":1312,"activeCount":97},[1313],{"nctId":1314,"briefTitle":1315,"status":595,"phases":1316,"primaryCompletion":1317,"completion":1317,"start":1318,"enrollment":599,"conditions":1319,"interventions":1320},"NCT05971667","Effect of Tadalafil, Sildenafil and Pentoxyfylline on Frozen Embryo Transfer Outcomes",[87,88],"2023-10-30","2023-07-30",[15],[1321,1300,1322],"tadalafil","pentoxifylline",{"trials":1324,"activeCount":97},[1325],{"nctId":1290,"briefTitle":1291,"status":782,"phases":1326,"primaryCompletion":1293,"completion":1293,"start":1294,"enrollment":1295,"conditions":1327,"interventions":1328},[89],[1297],[1299,1300,1267],{"trials":1330,"activeCount":97},[],{"intervention":1262,"totalTrials":569,"cells":1332},{"EARLY_PHASE1":1333,"PHASE1":1335,"PHASE2":1337,"PHASE3":1339,"PHASE4":1347,"NA":1353},{"trials":1334,"activeCount":97},[],{"trials":1336,"activeCount":97},[],{"trials":1338,"activeCount":97},[],{"trials":1340,"activeCount":97},[1341],{"nctId":1342,"briefTitle":1343,"status":595,"phases":1344,"primaryCompletion":1317,"completion":1317,"start":1318,"enrollment":1168,"conditions":1345,"interventions":1346},"NCT05972928","Effect of Sitagliptin on Polycystic Ovarian Syndrome Patients",[87,88],[1121],[1262],{"trials":1348,"activeCount":97},[1349],{"nctId":1252,"briefTitle":1253,"status":782,"phases":1350,"primaryCompletion":1255,"completion":1256,"start":1257,"enrollment":633,"conditions":1351,"interventions":1352},[89],[1259],[1261,1262,1263],{"trials":1354,"activeCount":97},[],{"intervention":1094,"totalTrials":569,"cells":1356},{"EARLY_PHASE1":1357,"PHASE1":1359,"PHASE2":1361,"PHASE3":1363,"PHASE4":1365,"NA":1375},{"trials":1358,"activeCount":97},[],{"trials":1360,"activeCount":97},[],{"trials":1362,"activeCount":97},[],{"trials":1364,"activeCount":97},[],{"trials":1366,"activeCount":97},[1367,1371],{"nctId":1086,"briefTitle":1087,"status":595,"phases":1368,"primaryCompletion":1089,"completion":1089,"start":1090,"enrollment":599,"conditions":1369,"interventions":1370},[89],[1092],[1094,1062],{"nctId":1096,"briefTitle":1097,"status":595,"phases":1372,"primaryCompletion":1099,"completion":1099,"start":1090,"enrollment":599,"conditions":1373,"interventions":1374},[89],[1092],[1094,1062],{"trials":1376,"activeCount":97},[],{"intervention":1147,"totalTrials":93,"cells":1378},{"EARLY_PHASE1":1379,"PHASE1":1381,"PHASE2":1383,"PHASE3":1385,"PHASE4":1387,"NA":1393},{"trials":1380,"activeCount":97},[],{"trials":1382,"activeCount":97},[],{"trials":1384,"activeCount":97},[],{"trials":1386,"activeCount":97},[],{"trials":1388,"activeCount":97},[1389],{"nctId":1136,"briefTitle":1137,"status":782,"phases":1390,"primaryCompletion":1139,"completion":1140,"start":1141,"enrollment":1142,"conditions":1391,"interventions":1392},[89],[1144],[1146,1147,1148,1149],{"trials":1394,"activeCount":97},[],{"intervention":1148,"totalTrials":93,"cells":1396},{"EARLY_PHASE1":1397,"PHASE1":1399,"PHASE2":1401,"PHASE3":1403,"PHASE4":1405,"NA":1411},{"trials":1398,"activeCount":97},[],{"trials":1400,"activeCount":97},[],{"trials":1402,"activeCount":97},[],{"trials":1404,"activeCount":97},[],{"trials":1406,"activeCount":97},[1407],{"nctId":1136,"briefTitle":1137,"status":782,"phases":1408,"primaryCompletion":1139,"completion":1140,"start":1141,"enrollment":1142,"conditions":1409,"interventions":1410},[89],[1144],[1146,1147,1148,1149],{"trials":1412,"activeCount":97},[],{"intervention":1414,"totalTrials":93,"cells":1415},"Oral intake of medication",{"EARLY_PHASE1":1416,"PHASE1":1418,"PHASE2":1420,"PHASE3":1422,"PHASE4":1424,"NA":1436},{"trials":1417,"activeCount":97},[],{"trials":1419,"activeCount":97},[],{"trials":1421,"activeCount":97},[],{"trials":1423,"activeCount":97},[],{"trials":1425,"activeCount":97},[1426],{"nctId":1427,"briefTitle":1428,"status":782,"phases":1429,"primaryCompletion":798,"completion":1430,"start":1431,"enrollment":1432,"conditions":1433,"interventions":1435},"NCT07113145","Comparative Evaluation of Safety and Efficacy of Dapoxetine, Silodosin, and Citalopram in the Management of Premature Ejaculation",[89],"2025-03-01","2024-06-01",450,[1434],"Premature (Early) Ejaculation",[1414,1414,1414,1414],{"trials":1437,"activeCount":97},[],{"intervention":1299,"totalTrials":93,"cells":1439},{"EARLY_PHASE1":1440,"PHASE1":1442,"PHASE2":1444,"PHASE3":1446,"PHASE4":1448,"NA":1454},{"trials":1441,"activeCount":97},[],{"trials":1443,"activeCount":97},[],{"trials":1445,"activeCount":97},[],{"trials":1447,"activeCount":97},[],{"trials":1449,"activeCount":97},[1450],{"nctId":1290,"briefTitle":1291,"status":782,"phases":1451,"primaryCompletion":1293,"completion":1293,"start":1294,"enrollment":1295,"conditions":1452,"interventions":1453},[89],[1297],[1299,1300,1267],{"trials":1455,"activeCount":97},[],{"intervention":1457,"totalTrials":93,"cells":1458},"Trimetazidine 35 mg",{"EARLY_PHASE1":1459,"PHASE1":1461,"PHASE2":1463,"PHASE3":1465,"PHASE4":1467,"NA":1481},{"trials":1460,"activeCount":97},[],{"trials":1462,"activeCount":97},[],{"trials":1464,"activeCount":97},[],{"trials":1466,"activeCount":97},[],{"trials":1468,"activeCount":97},[1469],{"nctId":1470,"briefTitle":1471,"status":595,"phases":1472,"primaryCompletion":1473,"completion":1473,"start":1474,"enrollment":1475,"conditions":1476,"interventions":1478},"NCT05540184","Allopurinol and Trimetazidine as a Preventive of Acute Kidney Injury in PCI Patients",[89],"2025-09","2022-09-19",124,[1477],"AKI - Acute Kidney Injury",[1457,1479,1480],"Allopurinol 300 MG","Normal saline",{"trials":1482,"activeCount":97},[],{"intervention":1479,"totalTrials":93,"cells":1484},{"EARLY_PHASE1":1485,"PHASE1":1487,"PHASE2":1489,"PHASE3":1491,"PHASE4":1493,"NA":1499},{"trials":1486,"activeCount":97},[],{"trials":1488,"activeCount":97},[],{"trials":1490,"activeCount":97},[],{"trials":1492,"activeCount":97},[],{"trials":1494,"activeCount":97},[1495],{"nctId":1470,"briefTitle":1471,"status":595,"phases":1496,"primaryCompletion":1473,"completion":1473,"start":1474,"enrollment":1475,"conditions":1497,"interventions":1498},[89],[1477],[1457,1479,1480],{"trials":1500,"activeCount":97},[],{"intervention":1480,"totalTrials":93,"cells":1502},{"EARLY_PHASE1":1503,"PHASE1":1505,"PHASE2":1507,"PHASE3":1509,"PHASE4":1511,"NA":1517},{"trials":1504,"activeCount":97},[],{"trials":1506,"activeCount":97},[],{"trials":1508,"activeCount":97},[],{"trials":1510,"activeCount":97},[],{"trials":1512,"activeCount":97},[1513],{"nctId":1470,"briefTitle":1471,"status":595,"phases":1514,"primaryCompletion":1473,"completion":1473,"start":1474,"enrollment":1475,"conditions":1515,"interventions":1516},[89],[1477],[1457,1479,1480],{"trials":1518,"activeCount":97},[],{"intervention":1196,"totalTrials":93,"cells":1520},{"EARLY_PHASE1":1521,"PHASE1":1523,"PHASE2":1525,"PHASE3":1527,"PHASE4":1529,"NA":1535},{"trials":1522,"activeCount":97},[],{"trials":1524,"activeCount":97},[],{"trials":1526,"activeCount":97},[],{"trials":1528,"activeCount":97},[],{"trials":1530,"activeCount":97},[1531],{"nctId":1187,"briefTitle":1188,"status":782,"phases":1532,"primaryCompletion":1190,"completion":1190,"start":1191,"enrollment":1192,"conditions":1533,"interventions":1534},[89],[1194],[1196,1153],{"trials":1536,"activeCount":97},[],{"intervention":1538,"totalTrials":93,"cells":1539},"Ketamine Hydrochloride ,Magnesium sulphate and saline 0.9%",{"EARLY_PHASE1":1540,"PHASE1":1542,"PHASE2":1544,"PHASE3":1546,"PHASE4":1548,"NA":1562},{"trials":1541,"activeCount":97},[],{"trials":1543,"activeCount":97},[],{"trials":1545,"activeCount":97},[],{"trials":1547,"activeCount":97},[],{"trials":1549,"activeCount":97},[1550],{"nctId":1551,"briefTitle":1552,"status":595,"phases":1553,"primaryCompletion":1554,"completion":1555,"start":1076,"enrollment":933,"conditions":1556,"interventions":1561},"NCT05714540","Effect of Oropharyngeal Pack Soaked in Ketamine or Magnesium Sulphate on Post Operative Sore Throat After Nasal Surgery",[89],"2023-08","2023-09",[1557,1558,1559,1560],"Sore-throat","Nasopharyngeal Pack","Nasal Surgery","Nausea and Vomiting, Postoperative",[1538],{"trials":1563,"activeCount":97},[],{"intervention":1565,"totalTrials":93,"cells":1566},"transforaminal epidural injection.",{"EARLY_PHASE1":1567,"PHASE1":1569,"PHASE2":1571,"PHASE3":1573,"PHASE4":1575,"NA":1587},{"trials":1568,"activeCount":97},[],{"trials":1570,"activeCount":97},[],{"trials":1572,"activeCount":97},[],{"trials":1574,"activeCount":97},[],{"trials":1576,"activeCount":97},[1577],{"nctId":1578,"briefTitle":1579,"status":782,"phases":1580,"primaryCompletion":1581,"completion":1581,"start":1582,"enrollment":1583,"conditions":1584,"interventions":1586},"NCT05626283","Impact of Transforaminal Epidural Steroid Injection in Lumbar Disc Prolpse on Micro RNA-155 Serum Level",[89],"2023-09-01","2022-12-01",88,[1585],"Lumbar Disc Herniation",[1565],{"trials":1588,"activeCount":97},[],{"intervention":1590,"totalTrials":93,"cells":1591},"Pabal 100 mcg iv infusion over 1 minute given after delivery of fetal head",{"EARLY_PHASE1":1592,"PHASE1":1594,"PHASE2":1596,"PHASE3":1598,"PHASE4":1600,"NA":1613},{"trials":1593,"activeCount":97},[],{"trials":1595,"activeCount":97},[],{"trials":1597,"activeCount":97},[],{"trials":1599,"activeCount":97},[],{"trials":1601,"activeCount":97},[1602],{"nctId":1603,"briefTitle":1604,"status":782,"phases":1605,"primaryCompletion":1606,"completion":1606,"start":1607,"enrollment":599,"conditions":1608,"interventions":1611},"NCT02101567","Carbetocin Versus Oxytocin and Ergometrine for the Prevention of Postpartum Haemorrhage Following Caesarean Section",[89],"2015-04","2014-05",[1609,1610],"Bleeding","Anemia",[1590,1612],"Oxytocin 5 IU iv infusion and Methtergine 0.2 mg iv",{"trials":1614,"activeCount":97},[],{"intervention":1612,"totalTrials":93,"cells":1616},{"EARLY_PHASE1":1617,"PHASE1":1619,"PHASE2":1621,"PHASE3":1623,"PHASE4":1625,"NA":1631},{"trials":1618,"activeCount":97},[],{"trials":1620,"activeCount":97},[],{"trials":1622,"activeCount":97},[],{"trials":1624,"activeCount":97},[],{"trials":1626,"activeCount":97},[1627],{"nctId":1603,"briefTitle":1604,"status":782,"phases":1628,"primaryCompletion":1606,"completion":1606,"start":1607,"enrollment":599,"conditions":1629,"interventions":1630},[89],[1609,1610],[1590,1612],{"trials":1632,"activeCount":97},[],{"intervention":1634,"totalTrials":93,"cells":1635},"Dapagliflozin + Metformin",{"EARLY_PHASE1":1636,"PHASE1":1638,"PHASE2":1640,"PHASE3":1642,"PHASE4":1644,"NA":1658},{"trials":1637,"activeCount":97},[],{"trials":1639,"activeCount":97},[],{"trials":1641,"activeCount":97},[],{"trials":1643,"activeCount":97},[],{"trials":1645,"activeCount":97},[1646],{"nctId":1647,"briefTitle":1648,"status":782,"phases":1649,"primaryCompletion":1650,"completion":1651,"start":1652,"enrollment":1653,"conditions":1654,"interventions":1656},"NCT07363707","A Study Between Dapagliflozin and Empagliflozin Effect on NAFLD in Patients With Type 2 Diabetes.",[89],"2023-08-27","2024-03-01","2023-05-01",108,[1655],"NAFLD (Nonalcoholic Fatty Liver Disease)",[1634,1657],"Empa",{"trials":1659,"activeCount":97},[],{"intervention":1657,"totalTrials":93,"cells":1661},{"EARLY_PHASE1":1662,"PHASE1":1664,"PHASE2":1666,"PHASE3":1668,"PHASE4":1670,"NA":1676},{"trials":1663,"activeCount":97},[],{"trials":1665,"activeCount":97},[],{"trials":1667,"activeCount":97},[],{"trials":1669,"activeCount":97},[],{"trials":1671,"activeCount":97},[1672],{"nctId":1647,"briefTitle":1648,"status":782,"phases":1673,"primaryCompletion":1650,"completion":1651,"start":1652,"enrollment":1653,"conditions":1674,"interventions":1675},[89],[1655],[1634,1657],{"trials":1677,"activeCount":97},[],{"intervention":1679,"totalTrials":93,"cells":1680},"Saxagliptin 5mg",{"EARLY_PHASE1":1681,"PHASE1":1683,"PHASE2":1685,"PHASE3":1687,"PHASE4":1689,"NA":1699},{"trials":1682,"activeCount":97},[],{"trials":1684,"activeCount":97},[],{"trials":1686,"activeCount":97},[],{"trials":1688,"activeCount":97},[],{"trials":1690,"activeCount":97},[1691],{"nctId":1692,"briefTitle":1693,"status":782,"phases":1694,"primaryCompletion":1695,"completion":1696,"start":1177,"enrollment":1168,"conditions":1697,"interventions":1698},"NCT04521049","Tubular Markers in Response to Saxagliptin Therapy",[89],"2020-03-01","2020-04-01",[1259],[1679],{"trials":1700,"activeCount":97},[],{"intervention":1702,"totalTrials":93,"cells":1703},"Tadalafil versus tamsulosin as MET",{"EARLY_PHASE1":1704,"PHASE1":1706,"PHASE2":1708,"PHASE3":1710,"PHASE4":1712,"NA":1725},{"trials":1705,"activeCount":97},[],{"trials":1707,"activeCount":97},[],{"trials":1709,"activeCount":97},[],{"trials":1711,"activeCount":97},[],{"trials":1713,"activeCount":97},[1714],{"nctId":1715,"briefTitle":1716,"status":595,"phases":1717,"primaryCompletion":1718,"completion":1719,"start":1720,"enrollment":1721,"conditions":1722,"interventions":1724},"NCT04641507","Comparative Study Between Tadalafil Versus Tamsulosin as a Medical Expulsive Therapy for Lower Ureteric Stones",[89],"2022-03-03","2022-03-05","2020-01-01",166,[1723],"Lower Ureteric Stones",[1702],{"trials":1726,"activeCount":97},[],{"intervention":1261,"totalTrials":93,"cells":1728},{"EARLY_PHASE1":1729,"PHASE1":1731,"PHASE2":1733,"PHASE3":1735,"PHASE4":1737,"NA":1743},{"trials":1730,"activeCount":97},[],{"trials":1732,"activeCount":97},[],{"trials":1734,"activeCount":97},[],{"trials":1736,"activeCount":97},[],{"trials":1738,"activeCount":97},[1739],{"nctId":1252,"briefTitle":1253,"status":782,"phases":1740,"primaryCompletion":1255,"completion":1256,"start":1257,"enrollment":633,"conditions":1741,"interventions":1742},[89],[1259],[1261,1262,1263],{"trials":1744,"activeCount":97},[],{"intervention":1746,"totalTrials":93,"cells":1747},"Palbocicilib",{"EARLY_PHASE1":1748,"PHASE1":1750,"PHASE2":1752,"PHASE3":1754,"PHASE4":1756,"NA":1770},{"trials":1749,"activeCount":97},[],{"trials":1751,"activeCount":97},[],{"trials":1753,"activeCount":97},[],{"trials":1755,"activeCount":97},[],{"trials":1757,"activeCount":97},[1758],{"nctId":1759,"briefTitle":1760,"status":782,"phases":1761,"primaryCompletion":1762,"completion":1763,"start":1764,"enrollment":1765,"conditions":1766,"interventions":1767},"NCT07487129","Clinical and Pharmacoeconomic Assessment of CDK4\u002F6 Inhibitors for Treatment of Breast Cancer in Egypt",[89],"2025-10-20","2025-12-20","2024-08-25",206,[18],[1746,1768,1769],"Ribociclib","Abemaciclib",{"trials":1771,"activeCount":97},[],{"intervention":1768,"totalTrials":93,"cells":1773},{"EARLY_PHASE1":1774,"PHASE1":1776,"PHASE2":1778,"PHASE3":1780,"PHASE4":1782,"NA":1788},{"trials":1775,"activeCount":97},[],{"trials":1777,"activeCount":97},[],{"trials":1779,"activeCount":97},[],{"trials":1781,"activeCount":97},[],{"trials":1783,"activeCount":97},[1784],{"nctId":1759,"briefTitle":1760,"status":782,"phases":1785,"primaryCompletion":1762,"completion":1763,"start":1764,"enrollment":1765,"conditions":1786,"interventions":1787},[89],[18],[1746,1768,1769],{"trials":1789,"activeCount":97},[],{"intervention":1769,"totalTrials":93,"cells":1791},{"EARLY_PHASE1":1792,"PHASE1":1794,"PHASE2":1796,"PHASE3":1798,"PHASE4":1800,"NA":1806},{"trials":1793,"activeCount":97},[],{"trials":1795,"activeCount":97},[],{"trials":1797,"activeCount":97},[],{"trials":1799,"activeCount":97},[],{"trials":1801,"activeCount":97},[1802],{"nctId":1759,"briefTitle":1760,"status":782,"phases":1803,"primaryCompletion":1762,"completion":1763,"start":1764,"enrollment":1765,"conditions":1804,"interventions":1805},[89],[18],[1746,1768,1769],{"trials":1807,"activeCount":97},[],{"intervention":775,"totalTrials":93,"cells":1809},{"EARLY_PHASE1":1810,"PHASE1":1812,"PHASE2":1814,"PHASE3":1816,"PHASE4":1818,"NA":1824},{"trials":1811,"activeCount":97},[],{"trials":1813,"activeCount":97},[],{"trials":1815,"activeCount":97},[],{"trials":1817,"activeCount":97},[],{"trials":1819,"activeCount":97},[1820],{"nctId":766,"briefTitle":767,"status":595,"phases":1821,"primaryCompletion":598,"completion":769,"start":770,"enrollment":771,"conditions":1822,"interventions":1823},[89],[773],[753,775,776],{"trials":1825,"activeCount":97},[],{"intervention":776,"totalTrials":93,"cells":1827},{"EARLY_PHASE1":1828,"PHASE1":1830,"PHASE2":1832,"PHASE3":1834,"PHASE4":1836,"NA":1842},{"trials":1829,"activeCount":97},[],{"trials":1831,"activeCount":97},[],{"trials":1833,"activeCount":97},[],{"trials":1835,"activeCount":97},[],{"trials":1837,"activeCount":97},[1838],{"nctId":766,"briefTitle":767,"status":595,"phases":1839,"primaryCompletion":598,"completion":769,"start":770,"enrollment":771,"conditions":1840,"interventions":1841},[89],[773],[753,775,776],{"trials":1843,"activeCount":97},[],{"intervention":1845,"totalTrials":93,"cells":1846},"intravenous dexmedetomidine",{"EARLY_PHASE1":1847,"PHASE1":1849,"PHASE2":1851,"PHASE3":1853,"PHASE4":1855,"NA":1865},{"trials":1848,"activeCount":97},[],{"trials":1850,"activeCount":97},[],{"trials":1852,"activeCount":97},[],{"trials":1854,"activeCount":97},[],{"trials":1856,"activeCount":97},[1857],{"nctId":1858,"briefTitle":1859,"status":595,"phases":1860,"primaryCompletion":1861,"completion":1861,"start":1862,"enrollment":387,"conditions":1863,"interventions":1864},"NCT05965895","Ultrasound-Guided Continuous Serratus Anterior Plane Block vs Dexmedetomidine Infusion in Patients With Rib Fractures.",[89],"2024-08-01","2023-08-01",[21],[1845],{"trials":1866,"activeCount":97},[],{"intervention":1868,"totalTrials":93,"cells":1869},"Ciprofloxacin 400 MG\u002F200 ML Intravenous Solution",{"EARLY_PHASE1":1870,"PHASE1":1872,"PHASE2":1874,"PHASE3":1876,"PHASE4":1878,"NA":1891},{"trials":1871,"activeCount":97},[],{"trials":1873,"activeCount":97},[],{"trials":1875,"activeCount":97},[],{"trials":1877,"activeCount":97},[],{"trials":1879,"activeCount":97},[1880],{"nctId":1881,"briefTitle":1882,"status":782,"phases":1883,"primaryCompletion":1884,"completion":1885,"start":1886,"enrollment":599,"conditions":1887,"interventions":1889},"NCT04456712","Effect of Ciprofloxacin Versus Levofloxacin on QTc-interval and Dysglycemia",[89],"2018-11-30","2018-12-30","2018-06-01",[1888],"QTc Prolongation, Hyperglycemia, Hypoglycemia",[1868,1890],"Levofloxacin 750 MG",{"trials":1892,"activeCount":97},[],{"intervention":1890,"totalTrials":93,"cells":1894},{"EARLY_PHASE1":1895,"PHASE1":1897,"PHASE2":1899,"PHASE3":1901,"PHASE4":1903,"NA":1909},{"trials":1896,"activeCount":97},[],{"trials":1898,"activeCount":97},[],{"trials":1900,"activeCount":97},[],{"trials":1902,"activeCount":97},[],{"trials":1904,"activeCount":97},[1905],{"nctId":1881,"briefTitle":1882,"status":782,"phases":1906,"primaryCompletion":1884,"completion":1885,"start":1886,"enrollment":599,"conditions":1907,"interventions":1908},[89],[1888],[1868,1890],{"trials":1910,"activeCount":97},[],{"intervention":1171,"totalTrials":29,"cells":1912},{"EARLY_PHASE1":1913,"PHASE1":1915,"PHASE2":1917,"PHASE3":1923,"PHASE4":1944,"NA":1946},{"trials":1914,"activeCount":97},[],{"trials":1916,"activeCount":97},[],{"trials":1918,"activeCount":97},[1919],{"nctId":1162,"briefTitle":1163,"status":595,"phases":1920,"primaryCompletion":1165,"completion":1166,"start":1167,"enrollment":1168,"conditions":1921,"interventions":1922},[87],[18],[1171,1153],{"trials":1924,"activeCount":97},[1925,1934],{"nctId":1926,"briefTitle":1927,"status":782,"phases":1928,"primaryCompletion":1929,"completion":1929,"start":1129,"enrollment":387,"conditions":1930,"interventions":1932},"NCT05965908","Effect of Liraglutide in Obese Women With Polycystic Ovary Syndrome",[88],"2025-03-30",[1931],"Polycystic Ovary",[1933,1171],"liraglutide",{"nctId":1935,"briefTitle":1936,"status":782,"phases":1937,"primaryCompletion":1938,"completion":73,"start":1938,"enrollment":599,"conditions":1939,"interventions":1940},"NCT06405178","Adjuvant Therapy With Letrozole in Induction of Ovulation With Polycystic Ovarian Syndrome",[88],"2026-03-30",[1931],[1171,1941,1942,1943],"Dapagliflozin","Dapagliflozin\u002FMetformin","Letrozole",{"trials":1945,"activeCount":97},[],{"trials":1947,"activeCount":97},[],{"intervention":602,"totalTrials":569,"cells":1949},{"EARLY_PHASE1":1950,"PHASE1":1952,"PHASE2":1954,"PHASE3":1956,"PHASE4":1966,"NA":1968},{"trials":1951,"activeCount":97},[],{"trials":1953,"activeCount":97},[],{"trials":1955,"activeCount":97},[],{"trials":1957,"activeCount":97},[1958,1962],{"nctId":1116,"briefTitle":1117,"status":595,"phases":1959,"primaryCompletion":1119,"completion":1119,"start":598,"enrollment":152,"conditions":1960,"interventions":1961},[88],[1121],[602,1123,1124,1105],{"nctId":593,"briefTitle":594,"status":595,"phases":1963,"primaryCompletion":597,"completion":597,"start":598,"enrollment":599,"conditions":1964,"interventions":1965},[88],[15],[602,603,568,604],{"trials":1967,"activeCount":97},[],{"trials":1969,"activeCount":97},[],{"intervention":1942,"totalTrials":569,"cells":1971},{"EARLY_PHASE1":1972,"PHASE1":1974,"PHASE2":1976,"PHASE3":1978,"PHASE4":1994,"NA":1996},{"trials":1973,"activeCount":97},[],{"trials":1975,"activeCount":97},[],{"trials":1977,"activeCount":97},[],{"trials":1979,"activeCount":97},[1980,1990],{"nctId":1981,"briefTitle":1982,"status":595,"phases":1983,"primaryCompletion":1318,"completion":1318,"start":1984,"enrollment":599,"conditions":1985,"interventions":1987},"NCT05601336","of Sodium Glucose Cotransporter-2 Inhibitors on Metabolic, Hormonal and Clinical Parameters in PCO",[88],"2022-01-15",[1986],"PCO",[1988,1989,1942],"Dapagliflozin 5 MG","Metformin Hydrochloride 1000 MG",{"nctId":1935,"briefTitle":1936,"status":782,"phases":1991,"primaryCompletion":1938,"completion":73,"start":1938,"enrollment":599,"conditions":1992,"interventions":1993},[88],[1931],[1171,1941,1942,1943],{"trials":1995,"activeCount":97},[],{"trials":1997,"activeCount":97},[],{"intervention":1286,"totalTrials":569,"cells":1999},{"EARLY_PHASE1":2000,"PHASE1":2002,"PHASE2":2004,"PHASE3":2006,"PHASE4":2022,"NA":2024},{"trials":2001,"activeCount":97},[],{"trials":2003,"activeCount":97},[],{"trials":2005,"activeCount":97},[],{"trials":2007,"activeCount":97},[2008,2012],{"nctId":1278,"briefTitle":1279,"status":782,"phases":2009,"primaryCompletion":1281,"completion":1281,"start":1282,"enrollment":1283,"conditions":2010,"interventions":2011},[87,88],[154],[1286,1267],{"nctId":2013,"briefTitle":2014,"status":595,"phases":2015,"primaryCompletion":2016,"completion":2016,"start":2017,"enrollment":2018,"conditions":2019,"interventions":2020},"NCT05951413","The Effect of Sildenafil Citrate on Frozen Embryo Transfer Cycles",[87,88],"2023-09-30","2023-06-30",110,[15],[1286,2021],"estradiol",{"trials":2023,"activeCount":97},[],{"trials":2025,"activeCount":97},[],{"intervention":2027,"totalTrials":569,"cells":2028},"Omega 3",{"EARLY_PHASE1":2029,"PHASE1":2031,"PHASE2":2033,"PHASE3":2035,"PHASE4":2071,"NA":2073},{"trials":2030,"activeCount":97},[],{"trials":2032,"activeCount":97},[],{"trials":2034,"activeCount":97},[],{"trials":2036,"activeCount":97},[2037,2054],{"nctId":2038,"briefTitle":2039,"status":782,"phases":2040,"primaryCompletion":2041,"completion":2042,"start":2043,"enrollment":2044,"conditions":2045,"interventions":2049},"NCT04292314","Hydroxy Urea, Omega 3, Nigella Sativa,Honey on Oxidative Stress and Iron Chelation in Pediatric Major Thalassemia",[87,88],"2020-12-20","2021-01-20","2019-11-01",350,[2046,2047,2048],"Iron Overload","Oxidative Stress","Thalassemia Major",[2027,2050,2051,2052,2053],"Nigella Sativa Oil","Hydroxyurea","Honey","Deferoxamine",{"nctId":2055,"briefTitle":2056,"status":782,"phases":2057,"primaryCompletion":2058,"completion":2059,"start":2043,"enrollment":2044,"conditions":2060,"interventions":2064},"NCT04301336","Different Treatment Modalities in the Management of the Painful Crisis in Pediatric Sickle- Cell Anemia",[87,88],"2020-11-01","2020-12-10",[2061,2062,2063],"Vaso-occlusive Crisis","Sickle Cell Disease","Sickle Cell Anemia in Children",[2027,2065,2066,2067,2068,2069,2070],"Vit D","Zinc sulfate","Statins","Hydroxy Urea","Folic Acid Supplementation","Morphine Sulfate",{"trials":2072,"activeCount":97},[],{"trials":2074,"activeCount":97},[],{"intervention":2076,"totalTrials":569,"cells":2077},"Dydrogesterone",{"EARLY_PHASE1":2078,"PHASE1":2080,"PHASE2":2082,"PHASE3":2084,"PHASE4":2106,"NA":2108},{"trials":2079,"activeCount":97},[],{"trials":2081,"activeCount":97},[],{"trials":2083,"activeCount":97},[],{"trials":2085,"activeCount":97},[2086,2095],{"nctId":2087,"briefTitle":2088,"status":782,"phases":2089,"primaryCompletion":1938,"completion":2090,"start":2091,"enrollment":599,"conditions":2092,"interventions":2093},"NCT05951400","Progesterone Primed Protocol Versus GnRH Antagonist in With PCO Undergoing ICSI",[87,88],"2026-04-05","2024-01-01",[15,1986],[2076,2094],"Cetrorelix",{"nctId":2096,"briefTitle":2097,"status":595,"phases":2098,"primaryCompletion":2099,"completion":2099,"start":2100,"enrollment":2101,"conditions":2102,"interventions":2103},"NCT05972902","Dydrogesterone, Cetrorelix Acetate and Triptorelin in Intra Cytoplasmic Sperm Injection Outcomes",[88],"2023-12-31","2023-07-15",387,[15],[2076,2104,2105],"Cetrorelix acetate","Triptorelin",{"trials":2107,"activeCount":97},[],{"trials":2109,"activeCount":97},[],{"intervention":2111,"totalTrials":93,"cells":2112},"Yasmin",{"EARLY_PHASE1":2113,"PHASE1":2115,"PHASE2":2117,"PHASE3":2119,"PHASE4":2130,"NA":2132},{"trials":2114,"activeCount":97},[],{"trials":2116,"activeCount":97},[],{"trials":2118,"activeCount":97},[],{"trials":2120,"activeCount":97},[2121],{"nctId":2122,"briefTitle":2123,"status":782,"phases":2124,"primaryCompletion":2125,"completion":2125,"start":1607,"enrollment":2126,"conditions":2127,"interventions":2129},"NCT02089620","Comparison Between Oral Contraceptive Pills and Calcium Supplements in Treatment of Premenstrual Syndrome",[88],"2015-06",210,[2128],"Premenstrual Syndrome",[2111],{"trials":2131,"activeCount":97},[],{"trials":2133,"activeCount":97},[],{"intervention":1082,"totalTrials":93,"cells":2135},{"EARLY_PHASE1":2136,"PHASE1":2138,"PHASE2":2140,"PHASE3":2142,"PHASE4":2148,"NA":2150},{"trials":2137,"activeCount":97},[],{"trials":2139,"activeCount":97},[],{"trials":2141,"activeCount":97},[],{"trials":2143,"activeCount":97},[2144],{"nctId":1073,"briefTitle":1074,"status":782,"phases":2145,"primaryCompletion":1076,"completion":1077,"start":1078,"enrollment":933,"conditions":2146,"interventions":2147},[88],[1080],[1082,1062],{"trials":2149,"activeCount":97},[],{"trials":2151,"activeCount":97},[],{"intervention":1123,"totalTrials":93,"cells":2153},{"EARLY_PHASE1":2154,"PHASE1":2156,"PHASE2":2158,"PHASE3":2160,"PHASE4":2166,"NA":2168},{"trials":2155,"activeCount":97},[],{"trials":2157,"activeCount":97},[],{"trials":2159,"activeCount":97},[],{"trials":2161,"activeCount":97},[2162],{"nctId":1116,"briefTitle":1117,"status":595,"phases":2163,"primaryCompletion":1119,"completion":1119,"start":598,"enrollment":152,"conditions":2164,"interventions":2165},[88],[1121],[602,1123,1124,1105],{"trials":2167,"activeCount":97},[],{"trials":2169,"activeCount":97},[],{"intervention":1124,"totalTrials":93,"cells":2171},{"EARLY_PHASE1":2172,"PHASE1":2174,"PHASE2":2176,"PHASE3":2178,"PHASE4":2184,"NA":2186},{"trials":2173,"activeCount":97},[],{"trials":2175,"activeCount":97},[],{"trials":2177,"activeCount":97},[],{"trials":2179,"activeCount":97},[2180],{"nctId":1116,"briefTitle":1117,"status":595,"phases":2181,"primaryCompletion":1119,"completion":1119,"start":598,"enrollment":152,"conditions":2182,"interventions":2183},[88],[1121],[602,1123,1124,1105],{"trials":2185,"activeCount":97},[],{"trials":2187,"activeCount":97},[],{"intervention":2189,"totalTrials":93,"cells":2190},"Solu-Cortef",{"EARLY_PHASE1":2191,"PHASE1":2193,"PHASE2":2195,"PHASE3":2197,"PHASE4":2208,"NA":2210},{"trials":2192,"activeCount":97},[],{"trials":2194,"activeCount":97},[],{"trials":2196,"activeCount":97},[],{"trials":2198,"activeCount":97},[2199],{"nctId":2200,"briefTitle":2201,"status":595,"phases":2202,"primaryCompletion":2203,"completion":2203,"start":2204,"enrollment":824,"conditions":2205,"interventions":2207},"NCT05534334","Corticosteroid Intralesional Injection as an Alternative Treatment in Oral Pyogenic Granuloma in the Esthetic Zone.",[87,88],"2022-11-29","2022-05-01",[2206],"Oral Pyogenic Granuloma",[2189],{"trials":2209,"activeCount":97},[],{"trials":2211,"activeCount":97},[],{"intervention":1988,"totalTrials":93,"cells":2213},{"EARLY_PHASE1":2214,"PHASE1":2216,"PHASE2":2218,"PHASE3":2220,"PHASE4":2226,"NA":2228},{"trials":2215,"activeCount":97},[],{"trials":2217,"activeCount":97},[],{"trials":2219,"activeCount":97},[],{"trials":2221,"activeCount":97},[2222],{"nctId":1981,"briefTitle":1982,"status":595,"phases":2223,"primaryCompletion":1318,"completion":1318,"start":1984,"enrollment":599,"conditions":2224,"interventions":2225},[88],[1986],[1988,1989,1942],{"trials":2227,"activeCount":97},[],{"trials":2229,"activeCount":97},[],{"intervention":1989,"totalTrials":93,"cells":2231},{"EARLY_PHASE1":2232,"PHASE1":2234,"PHASE2":2236,"PHASE3":2238,"PHASE4":2244,"NA":2246},{"trials":2233,"activeCount":97},[],{"trials":2235,"activeCount":97},[],{"trials":2237,"activeCount":97},[],{"trials":2239,"activeCount":97},[2240],{"nctId":1981,"briefTitle":1982,"status":595,"phases":2241,"primaryCompletion":1318,"completion":1318,"start":1984,"enrollment":599,"conditions":2242,"interventions":2243},[88],[1986],[1988,1989,1942],{"trials":2245,"activeCount":97},[],{"trials":2247,"activeCount":97},[],{"intervention":2249,"totalTrials":93,"cells":2250},"Colistin",{"EARLY_PHASE1":2251,"PHASE1":2253,"PHASE2":2255,"PHASE3":2257,"PHASE4":2270,"NA":2272},{"trials":2252,"activeCount":97},[],{"trials":2254,"activeCount":97},[],{"trials":2256,"activeCount":97},[],{"trials":2258,"activeCount":97},[2259],{"nctId":2260,"briefTitle":2261,"status":782,"phases":2262,"primaryCompletion":2263,"completion":2264,"start":2265,"enrollment":2266,"conditions":2267,"interventions":2269},"NCT05689229","Aerosolized Versus Intravenous Colistin-based Antimicrobial Regimens in Hospitalized COVID-19 Patients With Bacterial Coinfection: A Randomized Controlled Trial",[88],"2021-11-28","2021-12-12","2021-08-03",128,[2268],"Secondary Bacterial Infection in COVID-19 Patients",[2249],{"trials":2271,"activeCount":97},[],{"trials":2273,"activeCount":97},[],{"intervention":2275,"totalTrials":93,"cells":2276},"myo-inositol",{"EARLY_PHASE1":2277,"PHASE1":2279,"PHASE2":2281,"PHASE3":2283,"PHASE4":2294,"NA":2296},{"trials":2278,"activeCount":97},[],{"trials":2280,"activeCount":97},[],{"trials":2282,"activeCount":97},[],{"trials":2284,"activeCount":97},[2285],{"nctId":2286,"briefTitle":2287,"status":595,"phases":2288,"primaryCompletion":2016,"completion":2016,"start":1318,"enrollment":799,"conditions":2289,"interventions":2291},"NCT05900661","The Effect of Myo-inositol, Somatropin, and DHEA on Poor Ovarian Responders",[87,88],[2290],"Poor Responders",[2275,2292,2293],"Somatropin","Dehydroepiandrosterone",{"trials":2295,"activeCount":97},[],{"trials":2297,"activeCount":97},[],{"intervention":2292,"totalTrials":93,"cells":2299},{"EARLY_PHASE1":2300,"PHASE1":2302,"PHASE2":2304,"PHASE3":2306,"PHASE4":2312,"NA":2314},{"trials":2301,"activeCount":97},[],{"trials":2303,"activeCount":97},[],{"trials":2305,"activeCount":97},[],{"trials":2307,"activeCount":97},[2308],{"nctId":2286,"briefTitle":2287,"status":595,"phases":2309,"primaryCompletion":2016,"completion":2016,"start":1318,"enrollment":799,"conditions":2310,"interventions":2311},[87,88],[2290],[2275,2292,2293],{"trials":2313,"activeCount":97},[],{"trials":2315,"activeCount":97},[],{"intervention":2293,"totalTrials":93,"cells":2317},{"EARLY_PHASE1":2318,"PHASE1":2320,"PHASE2":2322,"PHASE3":2324,"PHASE4":2330,"NA":2332},{"trials":2319,"activeCount":97},[],{"trials":2321,"activeCount":97},[],{"trials":2323,"activeCount":97},[],{"trials":2325,"activeCount":97},[2326],{"nctId":2286,"briefTitle":2287,"status":595,"phases":2327,"primaryCompletion":2016,"completion":2016,"start":1318,"enrollment":799,"conditions":2328,"interventions":2329},[87,88],[2290],[2275,2292,2293],{"trials":2331,"activeCount":97},[],{"trials":2333,"activeCount":97},[],{"intervention":2335,"totalTrials":93,"cells":2336},"Omega 3\u002FNigella Sativa Oil",{"EARLY_PHASE1":2337,"PHASE1":2339,"PHASE2":2341,"PHASE3":2343,"PHASE4":2360,"NA":2362},{"trials":2338,"activeCount":97},[],{"trials":2340,"activeCount":97},[],{"trials":2342,"activeCount":97},[],{"trials":2344,"activeCount":97},[2345],{"nctId":2346,"briefTitle":2347,"status":782,"phases":2348,"primaryCompletion":2349,"completion":2350,"start":2351,"enrollment":387,"conditions":2352,"interventions":2354},"NCT04553705","Omega-3, Nigella Sativa, Indian Costus, Quinine, Anise Seed, Deglycyrrhizinated Licorice, Artemisinin, Febrifugine on Immunity of Patients With (COVID-19)",[87,88],"2020-11-04","2021-12-04","2020-09-20",[31,2353],"Immunodeficiency",[2335,2355,2356,2357,2358,2359],"Omega 3\u002FNigella Sativa Oil\u002FIndian Costus","Omega 3\u002FNigella Sativa Oil\u002FQuinine pills","Omega 3\u002FNigella Sativa Oil\u002FAnise seed","Omega 3\u002FNigella Sativa Oil\u002FDeglycyrrhizinated Licorice","Active Comparator",{"trials":2361,"activeCount":97},[],{"trials":2363,"activeCount":97},[],{"intervention":2355,"totalTrials":93,"cells":2365},{"EARLY_PHASE1":2366,"PHASE1":2368,"PHASE2":2370,"PHASE3":2372,"PHASE4":2378,"NA":2380},{"trials":2367,"activeCount":97},[],{"trials":2369,"activeCount":97},[],{"trials":2371,"activeCount":97},[],{"trials":2373,"activeCount":97},[2374],{"nctId":2346,"briefTitle":2347,"status":782,"phases":2375,"primaryCompletion":2349,"completion":2350,"start":2351,"enrollment":387,"conditions":2376,"interventions":2377},[87,88],[31,2353],[2335,2355,2356,2357,2358,2359],{"trials":2379,"activeCount":97},[],{"trials":2381,"activeCount":97},[],{"intervention":2356,"totalTrials":93,"cells":2383},{"EARLY_PHASE1":2384,"PHASE1":2386,"PHASE2":2388,"PHASE3":2390,"PHASE4":2396,"NA":2398},{"trials":2385,"activeCount":97},[],{"trials":2387,"activeCount":97},[],{"trials":2389,"activeCount":97},[],{"trials":2391,"activeCount":97},[2392],{"nctId":2346,"briefTitle":2347,"status":782,"phases":2393,"primaryCompletion":2349,"completion":2350,"start":2351,"enrollment":387,"conditions":2394,"interventions":2395},[87,88],[31,2353],[2335,2355,2356,2357,2358,2359],{"trials":2397,"activeCount":97},[],{"trials":2399,"activeCount":97},[],{"intervention":2357,"totalTrials":93,"cells":2401},{"EARLY_PHASE1":2402,"PHASE1":2404,"PHASE2":2406,"PHASE3":2408,"PHASE4":2414,"NA":2416},{"trials":2403,"activeCount":97},[],{"trials":2405,"activeCount":97},[],{"trials":2407,"activeCount":97},[],{"trials":2409,"activeCount":97},[2410],{"nctId":2346,"briefTitle":2347,"status":782,"phases":2411,"primaryCompletion":2349,"completion":2350,"start":2351,"enrollment":387,"conditions":2412,"interventions":2413},[87,88],[31,2353],[2335,2355,2356,2357,2358,2359],{"trials":2415,"activeCount":97},[],{"trials":2417,"activeCount":97},[],{"intervention":2358,"totalTrials":93,"cells":2419},{"EARLY_PHASE1":2420,"PHASE1":2422,"PHASE2":2424,"PHASE3":2426,"PHASE4":2432,"NA":2434},{"trials":2421,"activeCount":97},[],{"trials":2423,"activeCount":97},[],{"trials":2425,"activeCount":97},[],{"trials":2427,"activeCount":97},[2428],{"nctId":2346,"briefTitle":2347,"status":782,"phases":2429,"primaryCompletion":2349,"completion":2350,"start":2351,"enrollment":387,"conditions":2430,"interventions":2431},[87,88],[31,2353],[2335,2355,2356,2357,2358,2359],{"trials":2433,"activeCount":97},[],{"trials":2435,"activeCount":97},[],{"intervention":2359,"totalTrials":93,"cells":2437},{"EARLY_PHASE1":2438,"PHASE1":2440,"PHASE2":2442,"PHASE3":2444,"PHASE4":2450,"NA":2452},{"trials":2439,"activeCount":97},[],{"trials":2441,"activeCount":97},[],{"trials":2443,"activeCount":97},[],{"trials":2445,"activeCount":97},[2446],{"nctId":2346,"briefTitle":2347,"status":782,"phases":2447,"primaryCompletion":2349,"completion":2350,"start":2351,"enrollment":387,"conditions":2448,"interventions":2449},[87,88],[31,2353],[2335,2355,2356,2357,2358,2359],{"trials":2451,"activeCount":97},[],{"trials":2453,"activeCount":97},[],{"intervention":2021,"totalTrials":93,"cells":2455},{"EARLY_PHASE1":2456,"PHASE1":2458,"PHASE2":2460,"PHASE3":2462,"PHASE4":2468,"NA":2470},{"trials":2457,"activeCount":97},[],{"trials":2459,"activeCount":97},[],{"trials":2461,"activeCount":97},[],{"trials":2463,"activeCount":97},[2464],{"nctId":2013,"briefTitle":2014,"status":595,"phases":2465,"primaryCompletion":2016,"completion":2016,"start":2017,"enrollment":2018,"conditions":2466,"interventions":2467},[87,88],[15],[1286,2021],{"trials":2469,"activeCount":97},[],{"trials":2471,"activeCount":97},[],{"intervention":2473,"totalTrials":93,"cells":2474},"4 IU of recombinant GH",{"EARLY_PHASE1":2475,"PHASE1":2477,"PHASE2":2479,"PHASE3":2481,"PHASE4":2492,"NA":2494},{"trials":2476,"activeCount":97},[],{"trials":2478,"activeCount":97},[],{"trials":2480,"activeCount":97},[],{"trials":2482,"activeCount":97},[2483],{"nctId":2484,"briefTitle":2485,"status":595,"phases":2486,"primaryCompletion":2487,"completion":1317,"start":2488,"enrollment":192,"conditions":2489,"interventions":2491},"NCT05602090","Growth Hormone For Poor Ovarian Reserve Patients in ICSI Trials",[87,88],"2023-09-04","2022-02-01",[2490],"Poor Ovarian Reserve",[2473],{"trials":2493,"activeCount":97},[],{"trials":2495,"activeCount":97},[],{"intervention":2497,"totalTrials":93,"cells":2498},"Intra ovarian by platelet rich plasma",{"EARLY_PHASE1":2499,"PHASE1":2501,"PHASE2":2503,"PHASE3":2505,"PHASE4":2516,"NA":2518},{"trials":2500,"activeCount":97},[],{"trials":2502,"activeCount":97},[],{"trials":2504,"activeCount":97},[],{"trials":2506,"activeCount":97},[2507],{"nctId":2508,"briefTitle":2509,"status":595,"phases":2510,"primaryCompletion":2511,"completion":2512,"start":1317,"enrollment":2513,"conditions":2514,"interventions":2515},"NCT06048666","Platelet Rich Plasma on Ovarian Reserve Parameters and Intra Cytoplasmic Sperm Injection Outcomes in Patients With Diminished Ovarian Reserve",[88],"2024-03-30","2024-09-30",56,[15],[2497],{"trials":2517,"activeCount":97},[],{"trials":2519,"activeCount":97},[],{"intervention":2521,"totalTrials":93,"cells":2522},"rosuvastatin drug",{"EARLY_PHASE1":2523,"PHASE1":2525,"PHASE2":2527,"PHASE3":2529,"PHASE4":2542,"NA":2544},{"trials":2524,"activeCount":97},[],{"trials":2526,"activeCount":97},[],{"trials":2528,"activeCount":97},[],{"trials":2530,"activeCount":97},[2531],{"nctId":2532,"briefTitle":2533,"status":782,"phases":2534,"primaryCompletion":2535,"completion":511,"start":2536,"enrollment":2537,"conditions":2538,"interventions":2540},"NCT07313124","Comparative Study Between Antihyperlipidemic Agents in Treatment of Cardiovascular Diseases",[87,88],"2025-11-20","2024-12-15",66,[2539],"Cardiovascular Diseases (CVD)",[2521,2541],"Patients received rosuvastatin ezetimibe10\u002F10mg",{"trials":2543,"activeCount":97},[],{"trials":2545,"activeCount":97},[],{"intervention":2541,"totalTrials":93,"cells":2547},{"EARLY_PHASE1":2548,"PHASE1":2550,"PHASE2":2552,"PHASE3":2554,"PHASE4":2560,"NA":2562},{"trials":2549,"activeCount":97},[],{"trials":2551,"activeCount":97},[],{"trials":2553,"activeCount":97},[],{"trials":2555,"activeCount":97},[2556],{"nctId":2532,"briefTitle":2533,"status":782,"phases":2557,"primaryCompletion":2535,"completion":511,"start":2536,"enrollment":2537,"conditions":2558,"interventions":2559},[87,88],[2539],[2521,2541],{"trials":2561,"activeCount":97},[],{"trials":2563,"activeCount":97},[],{"intervention":2565,"totalTrials":93,"cells":2566},"Apixaban",{"EARLY_PHASE1":2567,"PHASE1":2569,"PHASE2":2571,"PHASE3":2573,"PHASE4":2587,"NA":2589},{"trials":2568,"activeCount":97},[],{"trials":2570,"activeCount":97},[],{"trials":2572,"activeCount":97},[],{"trials":2574,"activeCount":97},[2575],{"nctId":2576,"briefTitle":2577,"status":595,"phases":2578,"primaryCompletion":2579,"completion":2580,"start":2581,"enrollment":152,"conditions":2582,"interventions":2585},"NCT04462003","Efficacy of Apixaban in Malignancy With Deep Venous Thrombosis",[88],"2020-07-02","2020-07-03","2019-07-03",[2583,2584],"Deep Vein Thrombosis","Malignancy",[2565,2586],"Enoxaparin",{"trials":2588,"activeCount":97},[],{"trials":2590,"activeCount":97},[],{"intervention":2586,"totalTrials":93,"cells":2592},{"EARLY_PHASE1":2593,"PHASE1":2595,"PHASE2":2597,"PHASE3":2599,"PHASE4":2605,"NA":2607},{"trials":2594,"activeCount":97},[],{"trials":2596,"activeCount":97},[],{"trials":2598,"activeCount":97},[],{"trials":2600,"activeCount":97},[2601],{"nctId":2576,"briefTitle":2577,"status":595,"phases":2602,"primaryCompletion":2579,"completion":2580,"start":2581,"enrollment":152,"conditions":2603,"interventions":2604},[88],[2583,2584],[2565,2586],{"trials":2606,"activeCount":97},[],{"trials":2608,"activeCount":97},[],{"intervention":2610,"totalTrials":93,"cells":2611},"VITAMIN B1 500mg",{"EARLY_PHASE1":2612,"PHASE1":2614,"PHASE2":2616,"PHASE3":2618,"PHASE4":2628,"NA":2630},{"trials":2613,"activeCount":97},[],{"trials":2615,"activeCount":97},[],{"trials":2617,"activeCount":97},[],{"trials":2619,"activeCount":97},[2620],{"nctId":2621,"briefTitle":2622,"status":595,"phases":2623,"primaryCompletion":2624,"completion":2624,"start":1318,"enrollment":599,"conditions":2625,"interventions":2627},"NCT05971680","the Effect of Vitamin B 1 on Menstrual Pattern After Insertion of the IUD.",[88],"2023-11-30",[2626],"Intra-uterine Device Complication",[2610],{"trials":2629,"activeCount":97},[],{"trials":2631,"activeCount":97},[],{"intervention":2050,"totalTrials":93,"cells":2633},{"EARLY_PHASE1":2634,"PHASE1":2636,"PHASE2":2638,"PHASE3":2640,"PHASE4":2646,"NA":2648},{"trials":2635,"activeCount":97},[],{"trials":2637,"activeCount":97},[],{"trials":2639,"activeCount":97},[],{"trials":2641,"activeCount":97},[2642],{"nctId":2038,"briefTitle":2039,"status":782,"phases":2643,"primaryCompletion":2041,"completion":2042,"start":2043,"enrollment":2044,"conditions":2644,"interventions":2645},[87,88],[2046,2047,2048],[2027,2050,2051,2052,2053],{"trials":2647,"activeCount":97},[],{"trials":2649,"activeCount":97},[],{"intervention":2051,"totalTrials":93,"cells":2651},{"EARLY_PHASE1":2652,"PHASE1":2654,"PHASE2":2656,"PHASE3":2658,"PHASE4":2664,"NA":2666},{"trials":2653,"activeCount":97},[],{"trials":2655,"activeCount":97},[],{"trials":2657,"activeCount":97},[],{"trials":2659,"activeCount":97},[2660],{"nctId":2038,"briefTitle":2039,"status":782,"phases":2661,"primaryCompletion":2041,"completion":2042,"start":2043,"enrollment":2044,"conditions":2662,"interventions":2663},[87,88],[2046,2047,2048],[2027,2050,2051,2052,2053],{"trials":2665,"activeCount":97},[],{"trials":2667,"activeCount":97},[],{"intervention":2052,"totalTrials":93,"cells":2669},{"EARLY_PHASE1":2670,"PHASE1":2672,"PHASE2":2674,"PHASE3":2676,"PHASE4":2682,"NA":2684},{"trials":2671,"activeCount":97},[],{"trials":2673,"activeCount":97},[],{"trials":2675,"activeCount":97},[],{"trials":2677,"activeCount":97},[2678],{"nctId":2038,"briefTitle":2039,"status":782,"phases":2679,"primaryCompletion":2041,"completion":2042,"start":2043,"enrollment":2044,"conditions":2680,"interventions":2681},[87,88],[2046,2047,2048],[2027,2050,2051,2052,2053],{"trials":2683,"activeCount":97},[],{"trials":2685,"activeCount":97},[],{"intervention":2053,"totalTrials":93,"cells":2687},{"EARLY_PHASE1":2688,"PHASE1":2690,"PHASE2":2692,"PHASE3":2694,"PHASE4":2700,"NA":2702},{"trials":2689,"activeCount":97},[],{"trials":2691,"activeCount":97},[],{"trials":2693,"activeCount":97},[],{"trials":2695,"activeCount":97},[2696],{"nctId":2038,"briefTitle":2039,"status":782,"phases":2697,"primaryCompletion":2041,"completion":2042,"start":2043,"enrollment":2044,"conditions":2698,"interventions":2699},[87,88],[2046,2047,2048],[2027,2050,2051,2052,2053],{"trials":2701,"activeCount":97},[],{"trials":2703,"activeCount":97},[],{"intervention":1933,"totalTrials":93,"cells":2705},{"EARLY_PHASE1":2706,"PHASE1":2708,"PHASE2":2710,"PHASE3":2712,"PHASE4":2718,"NA":2720},{"trials":2707,"activeCount":97},[],{"trials":2709,"activeCount":97},[],{"trials":2711,"activeCount":97},[],{"trials":2713,"activeCount":97},[2714],{"nctId":1926,"briefTitle":1927,"status":782,"phases":2715,"primaryCompletion":1929,"completion":1929,"start":1129,"enrollment":387,"conditions":2716,"interventions":2717},[88],[1931],[1933,1171],{"trials":2719,"activeCount":97},[],{"trials":2721,"activeCount":97},[],{"intervention":2723,"totalTrials":93,"cells":2724},"Unfractionated heparin",{"EARLY_PHASE1":2725,"PHASE1":2727,"PHASE2":2729,"PHASE3":2731,"PHASE4":2744,"NA":2746},{"trials":2726,"activeCount":97},[],{"trials":2728,"activeCount":97},[],{"trials":2730,"activeCount":97},[],{"trials":2732,"activeCount":97},[2733],{"nctId":2734,"briefTitle":2735,"status":782,"phases":2736,"primaryCompletion":2737,"completion":2737,"start":2738,"enrollment":633,"conditions":2739,"interventions":2742},"NCT03465085","Streptokinase Versus Unfractionated Heparin Nebulization in Severe ARDS",[88],"2018-01-30","2016-02-18",[2740,2741],"Acute Respiratory Distress Syndrome","Severe Acute Respiratory Syndrome",[2723,2743],"Streptokinase",{"trials":2745,"activeCount":97},[],{"trials":2747,"activeCount":97},[],{"intervention":2743,"totalTrials":93,"cells":2749},{"EARLY_PHASE1":2750,"PHASE1":2752,"PHASE2":2754,"PHASE3":2756,"PHASE4":2762,"NA":2764},{"trials":2751,"activeCount":97},[],{"trials":2753,"activeCount":97},[],{"trials":2755,"activeCount":97},[],{"trials":2757,"activeCount":97},[2758],{"nctId":2734,"briefTitle":2735,"status":782,"phases":2759,"primaryCompletion":2737,"completion":2737,"start":2738,"enrollment":633,"conditions":2760,"interventions":2761},[88],[2740,2741],[2723,2743],{"trials":2763,"activeCount":97},[],{"trials":2765,"activeCount":97},[],{"intervention":2767,"totalTrials":93,"cells":2768},"• The study will include 180 randomly selected patients who met inclusion criteria were randomized into four groups: silodosin 8 mg (Group A), tamsulosin 0.4 mg (Group B), silodosin 8 mg plus tadalaf",{"EARLY_PHASE1":2769,"PHASE1":2771,"PHASE2":2773,"PHASE3":2775,"PHASE4":2788,"NA":2790},{"trials":2770,"activeCount":97},[],{"trials":2772,"activeCount":97},[],{"trials":2774,"activeCount":97},[],{"trials":2776,"activeCount":97},[2777],{"nctId":2778,"briefTitle":2779,"status":782,"phases":2780,"primaryCompletion":2781,"completion":2782,"start":2783,"enrollment":2784,"conditions":2785,"interventions":2787},"NCT06707181","Comparative Study for Medical Therapy for Lower Ureteral Stones",[88],"2024-05-20","2024-08-18","2023-11-01",180,[2786],"Lower Ureteral Stones",[2767],{"trials":2789,"activeCount":97},[],{"trials":2791,"activeCount":97},[],{"intervention":2793,"totalTrials":93,"cells":2794},"BISMUTH TETRACYCLINE METRONIDAZOLE OMEPRAZOLE",{"EARLY_PHASE1":2795,"PHASE1":2797,"PHASE2":2799,"PHASE3":2801,"PHASE4":2813,"NA":2815},{"trials":2796,"activeCount":97},[],{"trials":2798,"activeCount":97},[],{"trials":2800,"activeCount":97},[],{"trials":2802,"activeCount":97},[2803],{"nctId":2804,"briefTitle":2805,"status":782,"phases":2806,"primaryCompletion":2807,"completion":2807,"start":2808,"enrollment":2809,"conditions":2810,"interventions":2812},"NCT07487142","Prevalence of Asymptomatic H Pylori Infection Among Patients Undergoing PCI and Impact of Its Eradication on Occurrence of GIT Symptoms and Bleeding\"",[88],"2025-12-24","2024-06-10",121,[2811],"H Pylori Infection",[2793],{"trials":2814,"activeCount":97},[],{"trials":2816,"activeCount":97},[],{"intervention":603,"totalTrials":93,"cells":2818},{"EARLY_PHASE1":2819,"PHASE1":2821,"PHASE2":2823,"PHASE3":2825,"PHASE4":2831,"NA":2833},{"trials":2820,"activeCount":97},[],{"trials":2822,"activeCount":97},[],{"trials":2824,"activeCount":97},[],{"trials":2826,"activeCount":97},[2827],{"nctId":593,"briefTitle":594,"status":595,"phases":2828,"primaryCompletion":597,"completion":597,"start":598,"enrollment":599,"conditions":2829,"interventions":2830},[88],[15],[602,603,568,604],{"trials":2832,"activeCount":97},[],{"trials":2834,"activeCount":97},[],{"intervention":604,"totalTrials":93,"cells":2836},{"EARLY_PHASE1":2837,"PHASE1":2839,"PHASE2":2841,"PHASE3":2843,"PHASE4":2849,"NA":2851},{"trials":2838,"activeCount":97},[],{"trials":2840,"activeCount":97},[],{"trials":2842,"activeCount":97},[],{"trials":2844,"activeCount":97},[2845],{"nctId":593,"briefTitle":594,"status":595,"phases":2846,"primaryCompletion":597,"completion":597,"start":598,"enrollment":599,"conditions":2847,"interventions":2848},[88],[15],[602,603,568,604],{"trials":2850,"activeCount":97},[],{"trials":2852,"activeCount":97},[],{"intervention":2065,"totalTrials":93,"cells":2854},{"EARLY_PHASE1":2855,"PHASE1":2857,"PHASE2":2859,"PHASE3":2861,"PHASE4":2867,"NA":2869},{"trials":2856,"activeCount":97},[],{"trials":2858,"activeCount":97},[],{"trials":2860,"activeCount":97},[],{"trials":2862,"activeCount":97},[2863],{"nctId":2055,"briefTitle":2056,"status":782,"phases":2864,"primaryCompletion":2058,"completion":2059,"start":2043,"enrollment":2044,"conditions":2865,"interventions":2866},[87,88],[2061,2062,2063],[2027,2065,2066,2067,2068,2069,2070],{"trials":2868,"activeCount":97},[],{"trials":2870,"activeCount":97},[],{"intervention":2066,"totalTrials":93,"cells":2872},{"EARLY_PHASE1":2873,"PHASE1":2875,"PHASE2":2877,"PHASE3":2879,"PHASE4":2885,"NA":2887},{"trials":2874,"activeCount":97},[],{"trials":2876,"activeCount":97},[],{"trials":2878,"activeCount":97},[],{"trials":2880,"activeCount":97},[2881],{"nctId":2055,"briefTitle":2056,"status":782,"phases":2882,"primaryCompletion":2058,"completion":2059,"start":2043,"enrollment":2044,"conditions":2883,"interventions":2884},[87,88],[2061,2062,2063],[2027,2065,2066,2067,2068,2069,2070],{"trials":2886,"activeCount":97},[],{"trials":2888,"activeCount":97},[],{"intervention":2067,"totalTrials":93,"cells":2890},{"EARLY_PHASE1":2891,"PHASE1":2893,"PHASE2":2895,"PHASE3":2897,"PHASE4":2903,"NA":2905},{"trials":2892,"activeCount":97},[],{"trials":2894,"activeCount":97},[],{"trials":2896,"activeCount":97},[],{"trials":2898,"activeCount":97},[2899],{"nctId":2055,"briefTitle":2056,"status":782,"phases":2900,"primaryCompletion":2058,"completion":2059,"start":2043,"enrollment":2044,"conditions":2901,"interventions":2902},[87,88],[2061,2062,2063],[2027,2065,2066,2067,2068,2069,2070],{"trials":2904,"activeCount":97},[],{"trials":2906,"activeCount":97},[],{"intervention":2068,"totalTrials":93,"cells":2908},{"EARLY_PHASE1":2909,"PHASE1":2911,"PHASE2":2913,"PHASE3":2915,"PHASE4":2921,"NA":2923},{"trials":2910,"activeCount":97},[],{"trials":2912,"activeCount":97},[],{"trials":2914,"activeCount":97},[],{"trials":2916,"activeCount":97},[2917],{"nctId":2055,"briefTitle":2056,"status":782,"phases":2918,"primaryCompletion":2058,"completion":2059,"start":2043,"enrollment":2044,"conditions":2919,"interventions":2920},[87,88],[2061,2062,2063],[2027,2065,2066,2067,2068,2069,2070],{"trials":2922,"activeCount":97},[],{"trials":2924,"activeCount":97},[],{"intervention":2069,"totalTrials":93,"cells":2926},{"EARLY_PHASE1":2927,"PHASE1":2929,"PHASE2":2931,"PHASE3":2933,"PHASE4":2939,"NA":2941},{"trials":2928,"activeCount":97},[],{"trials":2930,"activeCount":97},[],{"trials":2932,"activeCount":97},[],{"trials":2934,"activeCount":97},[2935],{"nctId":2055,"briefTitle":2056,"status":782,"phases":2936,"primaryCompletion":2058,"completion":2059,"start":2043,"enrollment":2044,"conditions":2937,"interventions":2938},[87,88],[2061,2062,2063],[2027,2065,2066,2067,2068,2069,2070],{"trials":2940,"activeCount":97},[],{"trials":2942,"activeCount":97},[],{"intervention":2070,"totalTrials":93,"cells":2944},{"EARLY_PHASE1":2945,"PHASE1":2947,"PHASE2":2949,"PHASE3":2951,"PHASE4":2957,"NA":2959},{"trials":2946,"activeCount":97},[],{"trials":2948,"activeCount":97},[],{"trials":2950,"activeCount":97},[],{"trials":2952,"activeCount":97},[2953],{"nctId":2055,"briefTitle":2056,"status":782,"phases":2954,"primaryCompletion":2058,"completion":2059,"start":2043,"enrollment":2044,"conditions":2955,"interventions":2956},[87,88],[2061,2062,2063],[2027,2065,2066,2067,2068,2069,2070],{"trials":2958,"activeCount":97},[],{"trials":2960,"activeCount":97},[],{"intervention":2094,"totalTrials":93,"cells":2962},{"EARLY_PHASE1":2963,"PHASE1":2965,"PHASE2":2967,"PHASE3":2969,"PHASE4":2975,"NA":2977},{"trials":2964,"activeCount":97},[],{"trials":2966,"activeCount":97},[],{"trials":2968,"activeCount":97},[],{"trials":2970,"activeCount":97},[2971],{"nctId":2087,"briefTitle":2088,"status":782,"phases":2972,"primaryCompletion":1938,"completion":2090,"start":2091,"enrollment":599,"conditions":2973,"interventions":2974},[87,88],[15,1986],[2076,2094],{"trials":2976,"activeCount":97},[],{"trials":2978,"activeCount":97},[],{"intervention":2104,"totalTrials":93,"cells":2980},{"EARLY_PHASE1":2981,"PHASE1":2983,"PHASE2":2985,"PHASE3":2987,"PHASE4":2993,"NA":2995},{"trials":2982,"activeCount":97},[],{"trials":2984,"activeCount":97},[],{"trials":2986,"activeCount":97},[],{"trials":2988,"activeCount":97},[2989],{"nctId":2096,"briefTitle":2097,"status":595,"phases":2990,"primaryCompletion":2099,"completion":2099,"start":2100,"enrollment":2101,"conditions":2991,"interventions":2992},[88],[15],[2076,2104,2105],{"trials":2994,"activeCount":97},[],{"trials":2996,"activeCount":97},[],{"intervention":2105,"totalTrials":93,"cells":2998},{"EARLY_PHASE1":2999,"PHASE1":3001,"PHASE2":3003,"PHASE3":3005,"PHASE4":3011,"NA":3013},{"trials":3000,"activeCount":97},[],{"trials":3002,"activeCount":97},[],{"trials":3004,"activeCount":97},[],{"trials":3006,"activeCount":97},[3007],{"nctId":2096,"briefTitle":2097,"status":595,"phases":3008,"primaryCompletion":2099,"completion":2099,"start":2100,"enrollment":2101,"conditions":3009,"interventions":3010},[88],[15],[2076,2104,2105],{"trials":3012,"activeCount":97},[],{"trials":3014,"activeCount":97},[],{"intervention":1941,"totalTrials":93,"cells":3016},{"EARLY_PHASE1":3017,"PHASE1":3019,"PHASE2":3021,"PHASE3":3023,"PHASE4":3029,"NA":3031},{"trials":3018,"activeCount":97},[],{"trials":3020,"activeCount":97},[],{"trials":3022,"activeCount":97},[],{"trials":3024,"activeCount":97},[3025],{"nctId":1935,"briefTitle":1936,"status":782,"phases":3026,"primaryCompletion":1938,"completion":73,"start":1938,"enrollment":599,"conditions":3027,"interventions":3028},[88],[1931],[1171,1941,1942,1943],{"trials":3030,"activeCount":97},[],{"trials":3032,"activeCount":97},[],{"intervention":1943,"totalTrials":93,"cells":3034},{"EARLY_PHASE1":3035,"PHASE1":3037,"PHASE2":3039,"PHASE3":3041,"PHASE4":3047,"NA":3049},{"trials":3036,"activeCount":97},[],{"trials":3038,"activeCount":97},[],{"trials":3040,"activeCount":97},[],{"trials":3042,"activeCount":97},[3043],{"nctId":1935,"briefTitle":1936,"status":782,"phases":3044,"primaryCompletion":1938,"completion":73,"start":1938,"enrollment":599,"conditions":3045,"interventions":3046},[88],[1931],[1171,1941,1942,1943],{"trials":3048,"activeCount":97},[],{"trials":3050,"activeCount":97},[],{"intervention":3052,"totalTrials":93,"cells":3053},"extended meropenem infusion in combination with other options such as Polymyxin, Tigecycline, Ertapenem, or Amikacin.",{"EARLY_PHASE1":3054,"PHASE1":3056,"PHASE2":3058,"PHASE3":3060,"PHASE4":3073,"NA":3075},{"trials":3055,"activeCount":97},[],{"trials":3057,"activeCount":97},[],{"trials":3059,"activeCount":97},[],{"trials":3061,"activeCount":97},[3062],{"nctId":3063,"briefTitle":3064,"status":782,"phases":3065,"primaryCompletion":1227,"completion":3066,"start":3067,"enrollment":3068,"conditions":3069,"interventions":3071},"NCT06739382","Management of Ventilation Acquired Pneumonia Caused by Pseudomonas and Acinetobacter Organisms in a Pediatric Center",[88],"2022-01-01","2021-01-01",64,[3070],"Ventilation Acquired Pneumonia",[3052,3072],"two β-lactam antibiotics plus a single non-β-lactam antibiotic",{"trials":3074,"activeCount":97},[],{"trials":3076,"activeCount":97},[],{"intervention":3072,"totalTrials":93,"cells":3078},{"EARLY_PHASE1":3079,"PHASE1":3081,"PHASE2":3083,"PHASE3":3085,"PHASE4":3091,"NA":3093},{"trials":3080,"activeCount":97},[],{"trials":3082,"activeCount":97},[],{"trials":3084,"activeCount":97},[],{"trials":3086,"activeCount":97},[3087],{"nctId":3063,"briefTitle":3064,"status":782,"phases":3088,"primaryCompletion":1227,"completion":3066,"start":3067,"enrollment":3068,"conditions":3089,"interventions":3090},[88],[3070],[3052,3072],{"trials":3092,"activeCount":97},[],{"trials":3094,"activeCount":97},[],{"intervention":1321,"totalTrials":93,"cells":3096},{"EARLY_PHASE1":3097,"PHASE1":3099,"PHASE2":3101,"PHASE3":3103,"PHASE4":3109,"NA":3111},{"trials":3098,"activeCount":97},[],{"trials":3100,"activeCount":97},[],{"trials":3102,"activeCount":97},[],{"trials":3104,"activeCount":97},[3105],{"nctId":1314,"briefTitle":1315,"status":595,"phases":3106,"primaryCompletion":1317,"completion":1317,"start":1318,"enrollment":599,"conditions":3107,"interventions":3108},[87,88],[15],[1321,1300,1322],{"trials":3110,"activeCount":97},[],{"trials":3112,"activeCount":97},[],{"intervention":3114,"totalTrials":93,"cells":3115},"Cefepime 1000 MG",{"EARLY_PHASE1":3116,"PHASE1":3118,"PHASE2":3120,"PHASE3":3122,"PHASE4":3136,"NA":3138},{"trials":3117,"activeCount":97},[],{"trials":3119,"activeCount":97},[],{"trials":3121,"activeCount":97},[],{"trials":3123,"activeCount":97},[3124],{"nctId":3125,"briefTitle":3126,"status":595,"phases":3127,"primaryCompletion":3128,"completion":3129,"start":3130,"enrollment":3131,"conditions":3132,"interventions":3134},"NCT06048692","Cefepime and Unictam on Preventing Post-Cesarean Surgical Site Infections",[88],"2023-09-15","2023-09-20","2023-01-01",213,[3133],"Cesarean Section; Infection",[3114,3135],"Ampicillin-sulbactam",{"trials":3137,"activeCount":97},[],{"trials":3139,"activeCount":97},[],{"intervention":3135,"totalTrials":93,"cells":3141},{"EARLY_PHASE1":3142,"PHASE1":3144,"PHASE2":3146,"PHASE3":3148,"PHASE4":3154,"NA":3156},{"trials":3143,"activeCount":97},[],{"trials":3145,"activeCount":97},[],{"trials":3147,"activeCount":97},[],{"trials":3149,"activeCount":97},[3150],{"nctId":3125,"briefTitle":3126,"status":595,"phases":3151,"primaryCompletion":3128,"completion":3129,"start":3130,"enrollment":3131,"conditions":3152,"interventions":3153},[88],[3133],[3114,3135],{"trials":3155,"activeCount":97},[],{"trials":3157,"activeCount":97},[],{"intervention":3159,"totalTrials":569,"cells":3160},"N-acetyl cysteine",{"EARLY_PHASE1":3161,"PHASE1":3163,"PHASE2":3174,"PHASE3":3185,"PHASE4":3187,"NA":3189},{"trials":3162,"activeCount":97},[],{"trials":3164,"activeCount":97},[3165],{"nctId":3166,"briefTitle":3167,"status":782,"phases":3168,"primaryCompletion":3169,"completion":3170,"start":3171,"enrollment":152,"conditions":3172,"interventions":3173},"NCT04260516","The Effect of N-acetylcysteine on Oxidative Stress Status and Iron Overload in Thalassemia Major",[86],"2019-12-03","2019-12-30","2019-06-03",[2048],[3159],{"trials":3175,"activeCount":97},[3176],{"nctId":3177,"briefTitle":3178,"status":782,"phases":3179,"primaryCompletion":3180,"completion":3130,"start":3181,"enrollment":957,"conditions":3182,"interventions":3184},"NCT04916080","N-acetyl Cysteine: the Effectiveness and Safety in a Cohort of Pediatric Patients With Chronic Kidney Disease",[87],"2022-06-01","2021-11-01",[3183],"Chronic Kidney Diseases",[3159],{"trials":3186,"activeCount":97},[],{"trials":3188,"activeCount":97},[],{"trials":3190,"activeCount":97},[],{"intervention":3192,"totalTrials":93,"cells":3193},"SOF\u002FSMV\u002FDCV\u002FRBV",{"EARLY_PHASE1":3194,"PHASE1":3196,"PHASE2":3198,"PHASE3":3209,"PHASE4":3211,"NA":3213},{"trials":3195,"activeCount":97},[],{"trials":3197,"activeCount":97},[],{"trials":3199,"activeCount":97},[3200],{"nctId":3201,"briefTitle":3202,"status":782,"phases":3203,"primaryCompletion":3204,"completion":3204,"start":3205,"enrollment":3206,"conditions":3207,"interventions":3208},"NCT04387539","ٍٍSofosbuvir\u002FSimeprevir\u002FDaclatasvir\u002FRibavirin and HCV Genotype 4-infected Egyptian Experienced Participants",[86,87],"2017-10-31","2017-03-01",94,[26],[3192],{"trials":3210,"activeCount":97},[],{"trials":3212,"activeCount":97},[],{"trials":3214,"activeCount":97},[],{"intervention":3216,"totalTrials":93,"cells":3217},"silodosin 8 mg capsule and the pyridostigmine bromide 60 mg",{"EARLY_PHASE1":3218,"PHASE1":3220,"PHASE2":3222,"PHASE3":3234,"PHASE4":3236,"NA":3238},{"trials":3219,"activeCount":97},[],{"trials":3221,"activeCount":97},[],{"trials":3223,"activeCount":97},[3224],{"nctId":3225,"briefTitle":3226,"status":782,"phases":3227,"primaryCompletion":1129,"completion":1129,"start":3228,"enrollment":3229,"conditions":3230,"interventions":3232},"NCT06319469","The Additive Value of Pyridostigmine to Silodosin in Acute Urinary Retention",[87],"2023-02-01",140,[3231],"Prostatic Hyperplasia",[3216,3233],"silodosin 8 mg",{"trials":3235,"activeCount":97},[],{"trials":3237,"activeCount":97},[],{"trials":3239,"activeCount":97},[],{"intervention":3233,"totalTrials":93,"cells":3241},{"EARLY_PHASE1":3242,"PHASE1":3244,"PHASE2":3246,"PHASE3":3252,"PHASE4":3254,"NA":3256},{"trials":3243,"activeCount":97},[],{"trials":3245,"activeCount":97},[],{"trials":3247,"activeCount":97},[3248],{"nctId":3225,"briefTitle":3226,"status":782,"phases":3249,"primaryCompletion":1129,"completion":1129,"start":3228,"enrollment":3229,"conditions":3250,"interventions":3251},[87],[3231],[3216,3233],{"trials":3253,"activeCount":97},[],{"trials":3255,"activeCount":97},[],{"trials":3257,"activeCount":97},[],{"intervention":3259,"totalTrials":93,"cells":3260},"Use of Bupivacaine in pectoral nerve block in mastectomy",{"EARLY_PHASE1":3261,"PHASE1":3263,"PHASE2":3265,"PHASE3":3278,"PHASE4":3280,"NA":3282},{"trials":3262,"activeCount":97},[],{"trials":3264,"activeCount":97},[],{"trials":3266,"activeCount":97},[3267],{"nctId":3268,"briefTitle":3269,"status":782,"phases":3270,"primaryCompletion":3271,"completion":1216,"start":1582,"enrollment":660,"conditions":3272,"interventions":3275},"NCT05663801","Magnesium Sulphate Versus Ketamine as an Adjuvant to Bupivacaine in Pectoral Nerve Block During Mastectomy",[87],"2023-12-01",[3273,3274],"Cancer","Breast",[3259,3276,3277],"use of Ketamine as adjuvants to bupivacaine in pectoral nerve block in mastectomy","Use of Magnesium Sulfate as adjuvants to bupivacaine in pectoral nerve block in mastectomy",{"trials":3279,"activeCount":97},[],{"trials":3281,"activeCount":97},[],{"trials":3283,"activeCount":97},[],{"intervention":3276,"totalTrials":93,"cells":3285},{"EARLY_PHASE1":3286,"PHASE1":3288,"PHASE2":3290,"PHASE3":3296,"PHASE4":3298,"NA":3300},{"trials":3287,"activeCount":97},[],{"trials":3289,"activeCount":97},[],{"trials":3291,"activeCount":97},[3292],{"nctId":3268,"briefTitle":3269,"status":782,"phases":3293,"primaryCompletion":3271,"completion":1216,"start":1582,"enrollment":660,"conditions":3294,"interventions":3295},[87],[3273,3274],[3259,3276,3277],{"trials":3297,"activeCount":97},[],{"trials":3299,"activeCount":97},[],{"trials":3301,"activeCount":97},[],{"intervention":3277,"totalTrials":93,"cells":3303},{"EARLY_PHASE1":3304,"PHASE1":3306,"PHASE2":3308,"PHASE3":3314,"PHASE4":3316,"NA":3318},{"trials":3305,"activeCount":97},[],{"trials":3307,"activeCount":97},[],{"trials":3309,"activeCount":97},[3310],{"nctId":3268,"briefTitle":3269,"status":782,"phases":3311,"primaryCompletion":3271,"completion":1216,"start":1582,"enrollment":660,"conditions":3312,"interventions":3313},[87],[3273,3274],[3259,3276,3277],{"trials":3315,"activeCount":97},[],{"trials":3317,"activeCount":97},[],{"trials":3319,"activeCount":97},[],{"intervention":3321,"totalTrials":93,"cells":3322},"capecitabine",{"EARLY_PHASE1":3323,"PHASE1":3325,"PHASE2":3327,"PHASE3":3336,"PHASE4":3338,"NA":3340},{"trials":3324,"activeCount":97},[],{"trials":3326,"activeCount":97},[],{"trials":3328,"activeCount":97},[3329],{"nctId":3330,"briefTitle":3331,"status":782,"phases":3332,"primaryCompletion":597,"completion":48,"start":3181,"enrollment":1168,"conditions":3333,"interventions":3335},"NCT07143097","Capecitabine as Maintenance Therapy vs Observation in Early-stage Triple-negative Breast Cancer",[87],[3334],"Triple -Negative Breast Cancer",[3321],{"trials":3337,"activeCount":97},[],{"trials":3339,"activeCount":97},[],{"trials":3341,"activeCount":97},[],{"intervention":3343,"totalTrials":93,"cells":3344},"Tritace",{"EARLY_PHASE1":3345,"PHASE1":3347,"PHASE2":3349,"PHASE3":3363,"PHASE4":3365,"NA":3367},{"trials":3346,"activeCount":97},[],{"trials":3348,"activeCount":97},[],{"trials":3350,"activeCount":97},[3351],{"nctId":3352,"briefTitle":3353,"status":595,"phases":3354,"primaryCompletion":3355,"completion":3356,"start":3357,"enrollment":3358,"conditions":3359,"interventions":3362},"NCT04143412","Efficacy of ACE Inhibitors, MRAs and ACE Inhibitor\u002F MRA Combination",[87],"2020-02","2020-03","2019-02-04",75,[3360,3361],"Diabetic Nephropathy Type 2","Microalbuminuria Due to Type 2 Diabetes Mellitus",[3343],{"trials":3364,"activeCount":97},[],{"trials":3366,"activeCount":97},[],{"trials":3368,"activeCount":97},[],{"intervention":3370,"totalTrials":93,"cells":3371},"Sofosbuvir + Simeprevir + Ribavirin",{"EARLY_PHASE1":3372,"PHASE1":3374,"PHASE2":3376,"PHASE3":3386,"PHASE4":3388,"NA":3390},{"trials":3373,"activeCount":97},[],{"trials":3375,"activeCount":97},[],{"trials":3377,"activeCount":97},[3378],{"nctId":3379,"briefTitle":3380,"status":782,"phases":3381,"primaryCompletion":3382,"completion":3382,"start":1606,"enrollment":3383,"conditions":3384,"interventions":3385},"NCT04385407","Sofosbuvir With Ribavirin or Simeprevir With HCV GT4 Egyptian Patients",[87],"2016-07",203,[26],[3370],{"trials":3387,"activeCount":97},[],{"trials":3389,"activeCount":97},[],{"trials":3391,"activeCount":97},[],{"intervention":1181,"totalTrials":93,"cells":3393},{"EARLY_PHASE1":3394,"PHASE1":3396,"PHASE2":3398,"PHASE3":3404,"PHASE4":3406,"NA":3408},{"trials":3395,"activeCount":97},[],{"trials":3397,"activeCount":97},[],{"trials":3399,"activeCount":97},[3400],{"nctId":1173,"briefTitle":1174,"status":595,"phases":3401,"primaryCompletion":1176,"completion":191,"start":1177,"enrollment":1168,"conditions":3402,"interventions":3403},[87],[1179],[1181,1153],{"trials":3405,"activeCount":97},[],{"trials":3407,"activeCount":97},[],{"trials":3409,"activeCount":97},[],{"intervention":3411,"totalTrials":93,"cells":3412},"Fentanyl Citrate",{"EARLY_PHASE1":3413,"PHASE1":3415,"PHASE2":3417,"PHASE3":3428,"PHASE4":3430,"NA":3432},{"trials":3414,"activeCount":97},[],{"trials":3416,"activeCount":97},[],{"trials":3418,"activeCount":97},[3419],{"nctId":3420,"briefTitle":3421,"status":595,"phases":3422,"primaryCompletion":620,"completion":620,"start":3423,"enrollment":3424,"conditions":3425,"interventions":3427},"NCT03903367","Thoracic Paravertebral Block Versus IV Fentanyl Infusion",[86,87],"2019-05",44,[3426],"Postoperative Pain",[3411],{"trials":3429,"activeCount":97},[],{"trials":3431,"activeCount":97},[],{"trials":3433,"activeCount":97},[],{"intervention":3435,"totalTrials":93,"cells":3436},"Tocilizumab",{"EARLY_PHASE1":3437,"PHASE1":3439,"PHASE2":3441,"PHASE3":3453,"PHASE4":3455,"NA":3457},{"trials":3438,"activeCount":97},[],{"trials":3440,"activeCount":97},[],{"trials":3442,"activeCount":97},[3443],{"nctId":3444,"briefTitle":3445,"status":782,"phases":3446,"primaryCompletion":3447,"completion":3448,"start":3449,"enrollment":152,"conditions":3450,"interventions":3451},"NCT04871854","Evaluating Tocilizumab for Sever COVID-19 Infection in Breast Cancer vs. Non Cancer Pateints",[87],"2022-07-26","2022-08-26","2021-04-26",[18],[3435,3452],"traditional Covid -19 therapy",{"trials":3454,"activeCount":97},[],{"trials":3456,"activeCount":97},[],{"trials":3458,"activeCount":97},[],{"intervention":3452,"totalTrials":93,"cells":3460},{"EARLY_PHASE1":3461,"PHASE1":3463,"PHASE2":3465,"PHASE3":3471,"PHASE4":3473,"NA":3475},{"trials":3462,"activeCount":97},[],{"trials":3464,"activeCount":97},[],{"trials":3466,"activeCount":97},[3467],{"nctId":3444,"briefTitle":3445,"status":782,"phases":3468,"primaryCompletion":3447,"completion":3448,"start":3449,"enrollment":152,"conditions":3469,"interventions":3470},[87],[18],[3435,3452],{"trials":3472,"activeCount":97},[],{"trials":3474,"activeCount":97},[],{"trials":3476,"activeCount":97},[],{"intervention":3478,"totalTrials":93,"cells":3479},"SOF\u002FRBV\u002FPegINFα-2",{"EARLY_PHASE1":3480,"PHASE1":3482,"PHASE2":3484,"PHASE3":3496,"PHASE4":3498,"NA":3500},{"trials":3481,"activeCount":97},[],{"trials":3483,"activeCount":97},[],{"trials":3485,"activeCount":97},[3486],{"nctId":3487,"briefTitle":3488,"status":782,"phases":3489,"primaryCompletion":3490,"completion":3490,"start":3491,"enrollment":3492,"conditions":3493,"interventions":3495},"NCT04382339","Sofosbuvir\u002FPegylated-interferon Plus Ribavirin With HCV Genotype 4",[86,87],"2015-11","2015-03",99,[3494],"Hepatitis C Virus Infection",[3478],{"trials":3497,"activeCount":97},[],{"trials":3499,"activeCount":97},[],{"trials":3501,"activeCount":97},[],{"intervention":3503,"totalTrials":93,"cells":3504},"Esmolol Hydrochloride",{"EARLY_PHASE1":3505,"PHASE1":3507,"PHASE2":3509,"PHASE3":3519,"PHASE4":3521,"NA":3523},{"trials":3506,"activeCount":97},[],{"trials":3508,"activeCount":97},[],{"trials":3510,"activeCount":97},[3511],{"nctId":3512,"briefTitle":3513,"status":595,"phases":3514,"primaryCompletion":620,"completion":620,"start":3515,"enrollment":3516,"conditions":3517,"interventions":3518},"NCT03892512","Dexmedetomidine and Esmolol Early Post Operative Cognitive Dysfunction",[86,87],"2019-04",58,[1230],[3503,1222],{"trials":3520,"activeCount":97},[],{"trials":3522,"activeCount":97},[],{"trials":3524,"activeCount":97},[],{"intervention":3526,"totalTrials":93,"cells":3527},"SOF plus (OBV\u002FPTV\u002Fr) plus RBV",{"EARLY_PHASE1":3528,"PHASE1":3530,"PHASE2":3532,"PHASE3":3541,"PHASE4":3543,"NA":3545},{"trials":3529,"activeCount":97},[],{"trials":3531,"activeCount":97},[],{"trials":3533,"activeCount":97},[3534],{"nctId":3535,"briefTitle":3536,"status":782,"phases":3537,"primaryCompletion":3204,"completion":3204,"start":3205,"enrollment":3538,"conditions":3539,"interventions":3540},"NCT04391985","Sofosbuvir\u002FOmbitasvir\u002FParitaprevir\u002F Ritonavir and Ribavirin for Hepatitis C Virus Genotype 4 Patients",[86,87],113,[26],[3526],{"trials":3542,"activeCount":97},[],{"trials":3544,"activeCount":97},[],{"trials":3546,"activeCount":97},[],{"intervention":3548,"totalTrials":93,"cells":3549},"intraarticular",{"EARLY_PHASE1":3550,"PHASE1":3552,"PHASE2":3554,"PHASE3":3565,"PHASE4":3567,"NA":3569},{"trials":3551,"activeCount":97},[],{"trials":3553,"activeCount":97},[],{"trials":3555,"activeCount":97},[3556],{"nctId":3557,"briefTitle":3558,"status":782,"phases":3559,"primaryCompletion":3560,"completion":3561,"start":1431,"enrollment":824,"conditions":3562,"interventions":3564},"NCT06403046","Does Successive Intra-articular Injections of Tenoxicam or Meloxicam Affect Treatment of TMJ Displacement",[86,87],"2025-05-07","2025-09-07",[3563],"Temporomandibular Joint Disc Displacement, With Reduction",[3548],{"trials":3566,"activeCount":97},[],{"trials":3568,"activeCount":97},[],{"trials":3570,"activeCount":97},[],{"intervention":3572,"totalTrials":93,"cells":3573},"Duloxetine alone",{"EARLY_PHASE1":3574,"PHASE1":3576,"PHASE2":3578,"PHASE3":3591,"PHASE4":3593,"NA":3595},{"trials":3575,"activeCount":97},[],{"trials":3577,"activeCount":97},[],{"trials":3579,"activeCount":97},[3580],{"nctId":3581,"briefTitle":3582,"status":595,"phases":3583,"primaryCompletion":2512,"completion":1119,"start":3584,"enrollment":3585,"conditions":3586,"interventions":3588},"NCT06091553","Comparison of the Efficacy and Safety of Duloxetine Augmented With Gabapentin and Duloxetine Augmented With Amitriptyline vs Duloxetine Alone in Chemotherapy -Induced Neuropathy",[87],"2023-10-10",160,[3587],"Neuropathy in Cacer Patien",[3572,3589,3590],"Duloxetine augmented with gabapentin","Duloxetine augmented with amitriptyline",{"trials":3592,"activeCount":97},[],{"trials":3594,"activeCount":97},[],{"trials":3596,"activeCount":97},[],{"intervention":3589,"totalTrials":93,"cells":3598},{"EARLY_PHASE1":3599,"PHASE1":3601,"PHASE2":3603,"PHASE3":3609,"PHASE4":3611,"NA":3613},{"trials":3600,"activeCount":97},[],{"trials":3602,"activeCount":97},[],{"trials":3604,"activeCount":97},[3605],{"nctId":3581,"briefTitle":3582,"status":595,"phases":3606,"primaryCompletion":2512,"completion":1119,"start":3584,"enrollment":3585,"conditions":3607,"interventions":3608},[87],[3587],[3572,3589,3590],{"trials":3610,"activeCount":97},[],{"trials":3612,"activeCount":97},[],{"trials":3614,"activeCount":97},[],{"intervention":3590,"totalTrials":93,"cells":3616},{"EARLY_PHASE1":3617,"PHASE1":3619,"PHASE2":3621,"PHASE3":3627,"PHASE4":3629,"NA":3631},{"trials":3618,"activeCount":97},[],{"trials":3620,"activeCount":97},[],{"trials":3622,"activeCount":97},[3623],{"nctId":3581,"briefTitle":3582,"status":595,"phases":3624,"primaryCompletion":2512,"completion":1119,"start":3584,"enrollment":3585,"conditions":3625,"interventions":3626},[87],[3587],[3572,3589,3590],{"trials":3628,"activeCount":97},[],{"trials":3630,"activeCount":97},[],{"trials":3632,"activeCount":97},[],{"intervention":3634,"totalTrials":93,"cells":3635},"OBV\u002FPTV\u002Fr) ± ribavirin",{"EARLY_PHASE1":3636,"PHASE1":3638,"PHASE2":3640,"PHASE3":3650,"PHASE4":3652,"NA":3654},{"trials":3637,"activeCount":97},[],{"trials":3639,"activeCount":97},[],{"trials":3641,"activeCount":97},[3642],{"nctId":3643,"briefTitle":3644,"status":782,"phases":3645,"primaryCompletion":3646,"completion":3646,"start":3647,"enrollment":152,"conditions":3648,"interventions":3649},"NCT04378608","Ombitasvir \u002FParitaprevir\u002FRitonavir Plus Ribavirin on HCV GT4",[86,87],"2017-09-08","2017-01-05",[3494],[3634],{"trials":3651,"activeCount":97},[],{"trials":3653,"activeCount":97},[],{"trials":3655,"activeCount":97},[],{"intervention":3657,"totalTrials":93,"cells":3658},"Metformin 850 mg twice daily for 3 months",{"EARLY_PHASE1":3659,"PHASE1":3661,"PHASE2":3672,"PHASE3":3674,"PHASE4":3676,"NA":3678},{"trials":3660,"activeCount":97},[],{"trials":3662,"activeCount":97},[3663],{"nctId":3664,"briefTitle":3665,"status":595,"phases":3666,"primaryCompletion":3667,"completion":3667,"start":3668,"enrollment":152,"conditions":3669,"interventions":3671},"NCT02244567","Effect of Metformin Therapy on Serum Under-carboxylated Osteocalcin Levels in Hyperandrogenic Lean Polycystic Ovarian Syndrome Women",[86],"2021-06","2014-09",[3670],"Polycystic Ovarian Syndrome",[3657],{"trials":3673,"activeCount":97},[],{"trials":3675,"activeCount":97},[],{"trials":3677,"activeCount":97},[],{"trials":3679,"activeCount":97},[],{"intervention":3681,"totalTrials":93,"cells":3682},"Transforaminal injection of Steroids alone",{"EARLY_PHASE1":3683,"PHASE1":3685,"PHASE2":3696,"PHASE3":3698,"PHASE4":3700,"NA":3702},{"trials":3684,"activeCount":97},[],{"trials":3686,"activeCount":97},[3687],{"nctId":3688,"briefTitle":3689,"status":782,"phases":3690,"primaryCompletion":3691,"completion":3692,"start":3693,"enrollment":1168,"conditions":3694,"interventions":3695},"NCT05288920","Effect of Pulsed Mode Radiofrequency as a Treatment of Lumbar Disc Related Radicular Pain on Tumor Necrotic Factor α Level",[86],"2022-09-01","2022-10-01","2022-03-01",[1585],[3681],{"trials":3697,"activeCount":97},[],{"trials":3699,"activeCount":97},[],{"trials":3701,"activeCount":97},[],{"trials":3703,"activeCount":97},[],{"intervention":3705,"totalTrials":93,"cells":3706},"Platelet rich fibrin gel in Orabase",{"EARLY_PHASE1":3707,"PHASE1":3709,"PHASE2":3724,"PHASE3":3726,"PHASE4":3728,"NA":3730},{"trials":3708,"activeCount":97},[],{"trials":3710,"activeCount":97},[3711],{"nctId":3712,"briefTitle":3713,"status":782,"phases":3714,"primaryCompletion":3715,"completion":3715,"start":3716,"enrollment":3717,"conditions":3718,"interventions":3722},"NCT03878771","PRF in Management of Chronic Multiple Oral Ulcers",[86],"2019-04-15","2019-03-13",804,[3719,3720,3721],"Oral Ulcer Due to Pemphius Vularis","Oral Ulcer Due to Benign Mucous Membrane Pemphioid","Oral Ulcer Due to Steven Johnson's Syndrome",[3705,3723],"Dermovate cream in Orabase",{"trials":3725,"activeCount":97},[],{"trials":3727,"activeCount":97},[],{"trials":3729,"activeCount":97},[],{"trials":3731,"activeCount":97},[],{"intervention":3723,"totalTrials":93,"cells":3733},{"EARLY_PHASE1":3734,"PHASE1":3736,"PHASE2":3742,"PHASE3":3744,"PHASE4":3746,"NA":3748},{"trials":3735,"activeCount":97},[],{"trials":3737,"activeCount":97},[3738],{"nctId":3712,"briefTitle":3713,"status":782,"phases":3739,"primaryCompletion":3715,"completion":3715,"start":3716,"enrollment":3717,"conditions":3740,"interventions":3741},[86],[3719,3720,3721],[3705,3723],{"trials":3743,"activeCount":97},[],{"trials":3745,"activeCount":97},[],{"trials":3747,"activeCount":97},[],{"trials":3749,"activeCount":97},[],{"intervention":3751,"totalTrials":93,"cells":3752},"hypotensive anaesthesia using Nitroglycerine",{"EARLY_PHASE1":3753,"PHASE1":3764,"PHASE2":3766,"PHASE3":3768,"PHASE4":3770,"NA":3772},{"trials":3754,"activeCount":97},[3755],{"nctId":3756,"briefTitle":3757,"status":595,"phases":3758,"primaryCompletion":1720,"completion":3759,"start":3760,"enrollment":633,"conditions":3761,"interventions":3763},"NCT04110808","Comparative Effect of Hypotensive Anaesthesia on Event Related Potentials, Quantitative Electroencephalograghy",[85],"2020-02-01","2019-10-15",[3762],"Effect of Drugs",[3751],{"trials":3765,"activeCount":97},[],{"trials":3767,"activeCount":97},[],{"trials":3769,"activeCount":97},[],{"trials":3771,"activeCount":97},[],{"trials":3773,"activeCount":97},[],{"intervention":3775,"totalTrials":93,"cells":3776},"adipose derived stem cells exosomes",{"EARLY_PHASE1":3777,"PHASE1":3790,"PHASE2":3792,"PHASE3":3794,"PHASE4":3796,"NA":3798},{"trials":3778,"activeCount":97},[3779],{"nctId":3780,"briefTitle":3781,"status":595,"phases":3782,"primaryCompletion":3783,"completion":3784,"start":3785,"enrollment":3786,"conditions":3787,"interventions":3789},"NCT04270006","Evaluation of Adipose Derived Stem Cells Exo.in Treatment of Periodontitis",[85],"2020-09-12","2021-10","2020-02-12",10,[3788],"Periodontitis",[3775],{"trials":3791,"activeCount":97},[],{"trials":3793,"activeCount":97},[],{"trials":3795,"activeCount":97},[],{"trials":3797,"activeCount":97},[],{"trials":3799,"activeCount":97},[],{"intervention":3801,"totalTrials":93,"cells":3802},"Botox injection in the prostate",{"EARLY_PHASE1":3803,"PHASE1":3814,"PHASE2":3816,"PHASE3":3818,"PHASE4":3820,"NA":3822},{"trials":3804,"activeCount":97},[3805],{"nctId":3806,"briefTitle":3807,"status":782,"phases":3808,"primaryCompletion":3809,"completion":3809,"start":3810,"enrollment":513,"conditions":3811,"interventions":3813},"NCT02524236","Effect of 50 and 100 IU Doses of Botox A Toxin Injection in BPH Patients.",[85],"2016-11","2015-08",[3812],"Benign Prostatic Hyperplasia",[3801],{"trials":3815,"activeCount":97},[],{"trials":3817,"activeCount":97},[],{"trials":3819,"activeCount":97},[],{"trials":3821,"activeCount":97},[],{"trials":3823,"activeCount":97},[],{"intervention":3825,"totalTrials":93,"cells":3826},"Rosuvastatin 20mg",{"EARLY_PHASE1":3827,"PHASE1":3840,"PHASE2":3842,"PHASE3":3844,"PHASE4":3846,"NA":3848},{"trials":3828,"activeCount":97},[3829],{"nctId":3830,"briefTitle":3831,"status":782,"phases":3832,"primaryCompletion":3833,"completion":3834,"start":3835,"enrollment":3836,"conditions":3837,"interventions":3839},"NCT06105060","Clinical Effects of New Approach on Patients With Non-alcoholic Steatohepatitis",[85],"2024-06-17","2024-06-27","2023-12-17",175,[3838],"Non-alcoholic Steatohepatitis",[3825],{"trials":3841,"activeCount":97},[],{"trials":3843,"activeCount":97},[],{"trials":3845,"activeCount":97},[],{"trials":3847,"activeCount":97},[],{"trials":3849,"activeCount":97},[],{"intervention":1222,"totalTrials":29,"cells":3851},{"EARLY_PHASE1":3852,"PHASE1":3854,"PHASE2":3856,"PHASE3":3862,"PHASE4":3864,"NA":3870},{"trials":3853,"activeCount":97},[],{"trials":3855,"activeCount":97},[],{"trials":3857,"activeCount":97},[3858],{"nctId":3512,"briefTitle":3513,"status":595,"phases":3859,"primaryCompletion":620,"completion":620,"start":3515,"enrollment":3516,"conditions":3860,"interventions":3861},[86,87],[1230],[3503,1222],{"trials":3863,"activeCount":97},[],{"trials":3865,"activeCount":97},[3866],{"nctId":1213,"briefTitle":1214,"status":595,"phases":3867,"primaryCompletion":822,"completion":822,"start":1216,"enrollment":1217,"conditions":3868,"interventions":3869},[89],[1219,1220],[1222,1200],{"trials":3871,"activeCount":97},[3872],{"nctId":3873,"briefTitle":3874,"status":595,"phases":3875,"primaryCompletion":1099,"completion":3876,"start":3877,"enrollment":633,"conditions":3878,"interventions":3879},"NCT04318158","Dexmedetomidine Versus Fentanyl as Adjuvants to Bupivacaine in Ultrasound Guided Transversus Abdominis Plane Block",[90],"2021-05","2020-04",[21],[3880,1222,3881],"Bupivacaine","Fentanyl",{"intervention":3883,"totalTrials":569,"cells":3884},"Magnesium Sulfate",{"EARLY_PHASE1":3885,"PHASE1":3897,"PHASE2":3899,"PHASE3":3901,"PHASE4":3903,"NA":3905},{"trials":3886,"activeCount":97},[3887],{"nctId":3888,"briefTitle":3889,"status":595,"phases":3890,"primaryCompletion":3891,"completion":3891,"start":3892,"enrollment":3893,"conditions":3894,"interventions":3896},"NCT04256057","Effect of Intraoperative Magnesium Infusion on Postoperative Pain and Cognitive Function",[85],"2020-04-15","2020-03-15",24,[3895],"the Effect of Intraoperative Magnesium Infusion on Postoperative Cognitive Functions in Adult Patients After Elective Pelvi-abdominal Surgeries",[3883],{"trials":3898,"activeCount":97},[],{"trials":3900,"activeCount":97},[],{"trials":3902,"activeCount":97},[],{"trials":3904,"activeCount":97},[],{"trials":3906,"activeCount":97},[3907],{"nctId":3908,"briefTitle":3909,"status":782,"phases":3910,"primaryCompletion":3911,"completion":1256,"start":3912,"enrollment":3913,"conditions":3914,"interventions":3916},"NCT05908864","Nebulized Versus Intravenous Magnesium Sulfate in Treatment of Asthma Exacerbation",[],"2019-11-22","2018-10-30",123,[3915],"Asthma Attack",[3917],"Magnesium sulfate",{"intervention":3919,"totalTrials":569,"cells":3920},"Atorvastatin 80mg",{"EARLY_PHASE1":3921,"PHASE1":3923,"PHASE2":3925,"PHASE3":3927,"PHASE4":3936,"NA":3938},{"trials":3922,"activeCount":97},[],{"trials":3924,"activeCount":97},[],{"trials":3926,"activeCount":97},[],{"trials":3928,"activeCount":97},[3929],{"nctId":3930,"briefTitle":3931,"status":595,"phases":3932,"primaryCompletion":770,"completion":597,"start":3933,"enrollment":633,"conditions":3934,"interventions":3935},"NCT05103644","Study of the Therapeutic Effect of Atorvastatin on the Clinical Outcomes in HER2 Negative Breast Cancer Patients\"",[87,88],"2021-10-30",[18],[3919],{"trials":3937,"activeCount":97},[],{"trials":3939,"activeCount":97},[3940],{"nctId":3941,"briefTitle":3942,"status":595,"phases":3943,"primaryCompletion":3944,"completion":3945,"start":3946,"enrollment":3492,"conditions":3947,"interventions":3949},"NCT04974814","Effect of Statin Preloading in STEMI in Improving PCI Outcomes",[90],"2022-10","2023-04","2021-05-26",[3948],"ST Elevation Myocardial Infarction",[3950,3919,3951],"Rosuvastatin 40mg","Control Test",{"intervention":3953,"totalTrials":569,"cells":3954},"Pentoxifylline",{"EARLY_PHASE1":3955,"PHASE1":3957,"PHASE2":3959,"PHASE3":3961,"PHASE4":3967,"NA":3969},{"trials":3956,"activeCount":97},[],{"trials":3958,"activeCount":97},[],{"trials":3960,"activeCount":97},[],{"trials":3962,"activeCount":97},[3963],{"nctId":1314,"briefTitle":1315,"status":595,"phases":3964,"primaryCompletion":1317,"completion":1317,"start":1318,"enrollment":599,"conditions":3965,"interventions":3966},[87,88],[15],[1321,1300,1322],{"trials":3968,"activeCount":97},[],{"trials":3970,"activeCount":97},[3971],{"nctId":3972,"briefTitle":3973,"status":782,"phases":3974,"primaryCompletion":3975,"completion":1861,"start":3976,"enrollment":660,"conditions":3977,"interventions":3979},"NCT06562998","Pentoxifylline Role Against Chemotherapy-induced Neuropathy",[90],"2024-04-01","2022-07-01",[3978],"Chemotherapy-induced Peripheral Neuropathy",[3953],{"intervention":3981,"totalTrials":569,"cells":3982},"azithromycin",{"EARLY_PHASE1":3983,"PHASE1":3985,"PHASE2":3987,"PHASE3":3989,"PHASE4":3999,"NA":4001},{"trials":3984,"activeCount":97},[],{"trials":3986,"activeCount":97},[],{"trials":3988,"activeCount":97},[],{"trials":3990,"activeCount":97},[3991],{"nctId":3992,"briefTitle":3993,"status":595,"phases":3994,"primaryCompletion":2016,"completion":3995,"start":1318,"enrollment":599,"conditions":3996,"interventions":3998},"NCT05971654","Effect Of Azithromycin in Women at Risk of Preterm Labour",[87,88],"2024-05-30",[3997],"Preterm Labor",[3981],{"trials":4000,"activeCount":97},[],{"trials":4002,"activeCount":97},[4003],{"nctId":4004,"briefTitle":4005,"status":782,"phases":4006,"primaryCompletion":4007,"completion":1281,"start":1282,"enrollment":599,"conditions":4008,"interventions":4010},"NCT05465304","Effect of Azithromycin in Preventing Premature Labour",[],"2022-04-01",[4009],"Pregnant With Complication",[4011],"Azithromycin",{"intervention":4013,"totalTrials":93,"cells":4014},"Solifenacin Succinate 5 MG",{"EARLY_PHASE1":4015,"PHASE1":4017,"PHASE2":4019,"PHASE3":4021,"PHASE4":4023,"NA":4025},{"trials":4016,"activeCount":97},[],{"trials":4018,"activeCount":97},[],{"trials":4020,"activeCount":97},[],{"trials":4022,"activeCount":97},[],{"trials":4024,"activeCount":97},[],{"trials":4026,"activeCount":97},[4027],{"nctId":4028,"briefTitle":4029,"status":782,"phases":4030,"primaryCompletion":4031,"completion":4031,"start":4032,"enrollment":633,"conditions":4033,"interventions":4035},"NCT04064619","Compare Sudden Stopping and Weaning of Anticholinergics in Recurrence of OAB Symptoms",[90],"2019-08-02","2018-01-01",[4034],"Voiding Disorders",[4013],{"intervention":4037,"totalTrials":93,"cells":4038},"Enoxaparin, Hydroxychloroquine",{"EARLY_PHASE1":4039,"PHASE1":4041,"PHASE2":4043,"PHASE3":4045,"PHASE4":4047,"NA":4049},{"trials":4040,"activeCount":97},[],{"trials":4042,"activeCount":97},[],{"trials":4044,"activeCount":97},[],{"trials":4046,"activeCount":97},[],{"trials":4048,"activeCount":97},[],{"trials":4050,"activeCount":97},[4051],{"nctId":4052,"briefTitle":4053,"status":782,"phases":4054,"primaryCompletion":1227,"completion":4055,"start":1228,"enrollment":599,"conditions":4056,"interventions":4058},"NCT05311813","Safety and Efficacy of Enoxaparin and Hydroxychloroquine in COVID-19",[90],"2021-12-30",[4057],"COVID-19 Pandemic",[4037],{"intervention":791,"totalTrials":93,"cells":4060},{"EARLY_PHASE1":4061,"PHASE1":4063,"PHASE2":4065,"PHASE3":4067,"PHASE4":4069,"NA":4071},{"trials":4062,"activeCount":97},[],{"trials":4064,"activeCount":97},[],{"trials":4066,"activeCount":97},[],{"trials":4068,"activeCount":97},[],{"trials":4070,"activeCount":97},[],{"trials":4072,"activeCount":97},[4073],{"nctId":780,"briefTitle":781,"status":782,"phases":4074,"primaryCompletion":784,"completion":785,"start":786,"enrollment":787,"conditions":4075,"interventions":4076},[],[789],[791,753],{"intervention":4078,"totalTrials":93,"cells":4079},"Ketamine",{"EARLY_PHASE1":4080,"PHASE1":4082,"PHASE2":4084,"PHASE3":4086,"PHASE4":4088,"NA":4090},{"trials":4081,"activeCount":97},[],{"trials":4083,"activeCount":97},[],{"trials":4085,"activeCount":97},[],{"trials":4087,"activeCount":97},[],{"trials":4089,"activeCount":97},[],{"trials":4091,"activeCount":97},[4092],{"nctId":4093,"briefTitle":4094,"status":782,"phases":4095,"primaryCompletion":1430,"completion":4096,"start":4097,"enrollment":4098,"conditions":4099,"interventions":4102},"NCT07074262","Comparison Between the Effect of Dexmedetomidine _midazolam and ketamine_midazolam Combination",[90],"2025-03-10","2024-10-10",114,[4100,4101],"Postoperative Cognitive Dysfunction","Post Operative Delirium",[4078],{"intervention":4104,"totalTrials":93,"cells":4105},"5ml saline",{"EARLY_PHASE1":4106,"PHASE1":4108,"PHASE2":4110,"PHASE3":4112,"PHASE4":4114,"NA":4116},{"trials":4107,"activeCount":97},[],{"trials":4109,"activeCount":97},[],{"trials":4111,"activeCount":97},[],{"trials":4113,"activeCount":97},[],{"trials":4115,"activeCount":97},[],{"trials":4117,"activeCount":97},[4118],{"nctId":4119,"briefTitle":4120,"status":595,"phases":4121,"primaryCompletion":4122,"completion":4122,"start":1607,"enrollment":771,"conditions":4123,"interventions":4125},"NCT02111148","Vaginal Fluid Wash in Pre-labour Rupture of Membranes",[90],"2021-12",[4124],"Disorder of Amniotic Cavity and\u002For Membrane",[4104],{"intervention":4127,"totalTrials":93,"cells":4128},"MEBO ointment",{"EARLY_PHASE1":4129,"PHASE1":4131,"PHASE2":4133,"PHASE3":4135,"PHASE4":4137,"NA":4139},{"trials":4130,"activeCount":97},[],{"trials":4132,"activeCount":97},[],{"trials":4134,"activeCount":97},[],{"trials":4136,"activeCount":97},[],{"trials":4138,"activeCount":97},[],{"trials":4140,"activeCount":97},[4141],{"nctId":4142,"briefTitle":4143,"status":782,"phases":4144,"primaryCompletion":1431,"completion":1139,"start":2091,"enrollment":633,"conditions":4145,"interventions":4148},"NCT06117904","Adjunctive Treatments for the Prevention of Radiotherapy-Induced Mucositis",[90],[4146,4147],"Radiotherapy Side Effect","Mucositis",[4127,4149],"Symptomatic treatment only",{"intervention":4149,"totalTrials":93,"cells":4151},{"EARLY_PHASE1":4152,"PHASE1":4154,"PHASE2":4156,"PHASE3":4158,"PHASE4":4160,"NA":4162},{"trials":4153,"activeCount":97},[],{"trials":4155,"activeCount":97},[],{"trials":4157,"activeCount":97},[],{"trials":4159,"activeCount":97},[],{"trials":4161,"activeCount":97},[],{"trials":4163,"activeCount":97},[4164],{"nctId":4142,"briefTitle":4143,"status":782,"phases":4165,"primaryCompletion":1431,"completion":1139,"start":2091,"enrollment":633,"conditions":4166,"interventions":4167},[90],[4146,4147],[4127,4149],{"intervention":4169,"totalTrials":93,"cells":4170},"clinical pharmacy application",{"EARLY_PHASE1":4171,"PHASE1":4173,"PHASE2":4175,"PHASE3":4177,"PHASE4":4179,"NA":4181},{"trials":4172,"activeCount":97},[],{"trials":4174,"activeCount":97},[],{"trials":4176,"activeCount":97},[],{"trials":4178,"activeCount":97},[],{"trials":4180,"activeCount":97},[],{"trials":4182,"activeCount":97},[4183],{"nctId":4184,"briefTitle":4185,"status":782,"phases":4186,"primaryCompletion":4187,"completion":4187,"start":3067,"enrollment":152,"conditions":4188,"interventions":4190},"NCT05531552","The Role of Clinical Pharmacist in Monitoring Drug Therapy in the Cardiovascular and Coronary Care Units in Libya.",[],"2022-06-30",[4189],"Coronary Artery Disease",[4169],{"intervention":4192,"totalTrials":93,"cells":4193},"Mg sulphate",{"EARLY_PHASE1":4194,"PHASE1":4196,"PHASE2":4198,"PHASE3":4200,"PHASE4":4202,"NA":4204},{"trials":4195,"activeCount":97},[],{"trials":4197,"activeCount":97},[],{"trials":4199,"activeCount":97},[],{"trials":4201,"activeCount":97},[],{"trials":4203,"activeCount":97},[],{"trials":4205,"activeCount":97},[4206],{"nctId":4207,"briefTitle":4208,"status":595,"phases":4209,"primaryCompletion":3228,"completion":4210,"start":4211,"enrollment":1168,"conditions":4212,"interventions":4214},"NCT05632159","Effect of Intraoperative Magnesium Sulphate on the Occurrence of Postoperative Delirium",[90],"2023-03-15","2022-11-01",[4213],"Patients Undergoing Lumbar Fixation",[4192,4215],"conventional anaesthesia",{"intervention":4215,"totalTrials":93,"cells":4217},{"EARLY_PHASE1":4218,"PHASE1":4220,"PHASE2":4222,"PHASE3":4224,"PHASE4":4226,"NA":4228},{"trials":4219,"activeCount":97},[],{"trials":4221,"activeCount":97},[],{"trials":4223,"activeCount":97},[],{"trials":4225,"activeCount":97},[],{"trials":4227,"activeCount":97},[],{"trials":4229,"activeCount":97},[4230],{"nctId":4207,"briefTitle":4208,"status":595,"phases":4231,"primaryCompletion":3228,"completion":4210,"start":4211,"enrollment":1168,"conditions":4232,"interventions":4233},[90],[4213],[4192,4215],{"intervention":4235,"totalTrials":93,"cells":4236},"lidocaine",{"EARLY_PHASE1":4237,"PHASE1":4239,"PHASE2":4241,"PHASE3":4243,"PHASE4":4245,"NA":4247},{"trials":4238,"activeCount":97},[],{"trials":4240,"activeCount":97},[],{"trials":4242,"activeCount":97},[],{"trials":4244,"activeCount":97},[],{"trials":4246,"activeCount":97},[],{"trials":4248,"activeCount":97},[4249],{"nctId":4250,"briefTitle":4251,"status":595,"phases":4252,"primaryCompletion":4253,"completion":4253,"start":1652,"enrollment":4254,"conditions":4255,"interventions":4257},"NCT05885230","Efficacy of Ultrasound Guided PIFB Versus Lidocaine Infusion on Postoperative Pain After Thoracotomy",[90],"2024-05",138,[4256],"Cardiac Surgery",[4235],{"intervention":3880,"totalTrials":93,"cells":4259},{"EARLY_PHASE1":4260,"PHASE1":4262,"PHASE2":4264,"PHASE3":4266,"PHASE4":4268,"NA":4270},{"trials":4261,"activeCount":97},[],{"trials":4263,"activeCount":97},[],{"trials":4265,"activeCount":97},[],{"trials":4267,"activeCount":97},[],{"trials":4269,"activeCount":97},[],{"trials":4271,"activeCount":97},[4272],{"nctId":3873,"briefTitle":3874,"status":595,"phases":4273,"primaryCompletion":1099,"completion":3876,"start":3877,"enrollment":633,"conditions":4274,"interventions":4275},[90],[21],[3880,1222,3881],{"intervention":3881,"totalTrials":93,"cells":4277},{"EARLY_PHASE1":4278,"PHASE1":4280,"PHASE2":4282,"PHASE3":4284,"PHASE4":4286,"NA":4288},{"trials":4279,"activeCount":97},[],{"trials":4281,"activeCount":97},[],{"trials":4283,"activeCount":97},[],{"trials":4285,"activeCount":97},[],{"trials":4287,"activeCount":97},[],{"trials":4289,"activeCount":97},[4290],{"nctId":3873,"briefTitle":3874,"status":595,"phases":4291,"primaryCompletion":1099,"completion":3876,"start":3877,"enrollment":633,"conditions":4292,"interventions":4293},[90],[21],[3880,1222,3881],{"intervention":4295,"totalTrials":93,"cells":4296},"Pregabalin 150mg",{"EARLY_PHASE1":4297,"PHASE1":4299,"PHASE2":4301,"PHASE3":4303,"PHASE4":4305,"NA":4307},{"trials":4298,"activeCount":97},[],{"trials":4300,"activeCount":97},[],{"trials":4302,"activeCount":97},[],{"trials":4304,"activeCount":97},[],{"trials":4306,"activeCount":97},[],{"trials":4308,"activeCount":97},[4309],{"nctId":4310,"briefTitle":4311,"status":782,"phases":4312,"primaryCompletion":4313,"completion":4313,"start":4314,"enrollment":4315,"conditions":4316,"interventions":4319},"NCT03721432","The Effect of Oral Pregabalin on Epidural-induced Shivering and Epidural Characteristics",[90],"2018-11-15","2018-05-20",77,[4317,4318],"Epidural Anesthesia","Shivering",[4295],{"intervention":4321,"totalTrials":93,"cells":4322},"Voriconazole Powder",{"EARLY_PHASE1":4323,"PHASE1":4325,"PHASE2":4327,"PHASE3":4329,"PHASE4":4331,"NA":4333},{"trials":4324,"activeCount":97},[],{"trials":4326,"activeCount":97},[],{"trials":4328,"activeCount":97},[],{"trials":4330,"activeCount":97},[],{"trials":4332,"activeCount":97},[],{"trials":4334,"activeCount":97},[4335],{"nctId":4336,"briefTitle":4337,"status":782,"phases":4338,"primaryCompletion":4339,"completion":598,"start":4340,"enrollment":4341,"conditions":4342,"interventions":4343},"NCT06392529","Efficacy of Voriconazole Loaded Spanlastics Gel Versus Clotriamazole Cream on Treating Vulvovaginal Candidasis",[],"2024-06-15","2024-05-10",28,[18],[4321],{"intervention":4345,"totalTrials":93,"cells":4346},"standard dose morphine",{"EARLY_PHASE1":4347,"PHASE1":4349,"PHASE2":4351,"PHASE3":4353,"PHASE4":4355,"NA":4357},{"trials":4348,"activeCount":97},[],{"trials":4350,"activeCount":97},[],{"trials":4352,"activeCount":97},[],{"trials":4354,"activeCount":97},[],{"trials":4356,"activeCount":97},[],{"trials":4358,"activeCount":97},[4359],{"nctId":4360,"briefTitle":4361,"status":595,"phases":4362,"primaryCompletion":4363,"completion":4363,"start":3228,"enrollment":633,"conditions":4364,"interventions":4368},"NCT05688371","Dexmedetomidine Plus Low Dose Morphine Versus Standard Dose of Morphine in PCA in Children .",[90],"2024-10-01",[4365,4366,1222,4367],"PCA","Children","Morphine",[4345,4369],"low dose morphine plus dexmedetomidine",{"intervention":4369,"totalTrials":93,"cells":4371},{"EARLY_PHASE1":4372,"PHASE1":4374,"PHASE2":4376,"PHASE3":4378,"PHASE4":4380,"NA":4382},{"trials":4373,"activeCount":97},[],{"trials":4375,"activeCount":97},[],{"trials":4377,"activeCount":97},[],{"trials":4379,"activeCount":97},[],{"trials":4381,"activeCount":97},[],{"trials":4383,"activeCount":97},[4384],{"nctId":4360,"briefTitle":4361,"status":595,"phases":4385,"primaryCompletion":4363,"completion":4363,"start":3228,"enrollment":633,"conditions":4386,"interventions":4387},[90],[4365,4366,1222,4367],[4345,4369],{"intervention":3950,"totalTrials":93,"cells":4389},{"EARLY_PHASE1":4390,"PHASE1":4392,"PHASE2":4394,"PHASE3":4396,"PHASE4":4398,"NA":4400},{"trials":4391,"activeCount":97},[],{"trials":4393,"activeCount":97},[],{"trials":4395,"activeCount":97},[],{"trials":4397,"activeCount":97},[],{"trials":4399,"activeCount":97},[],{"trials":4401,"activeCount":97},[4402],{"nctId":3941,"briefTitle":3942,"status":595,"phases":4403,"primaryCompletion":3944,"completion":3945,"start":3946,"enrollment":3492,"conditions":4404,"interventions":4405},[90],[3948],[3950,3919,3951],{"intervention":3951,"totalTrials":93,"cells":4407},{"EARLY_PHASE1":4408,"PHASE1":4410,"PHASE2":4412,"PHASE3":4414,"PHASE4":4416,"NA":4418},{"trials":4409,"activeCount":97},[],{"trials":4411,"activeCount":97},[],{"trials":4413,"activeCount":97},[],{"trials":4415,"activeCount":97},[],{"trials":4417,"activeCount":97},[],{"trials":4419,"activeCount":97},[4420],{"nctId":3941,"briefTitle":3942,"status":595,"phases":4421,"primaryCompletion":3944,"completion":3945,"start":3946,"enrollment":3492,"conditions":4422,"interventions":4423},[90],[3948],[3950,3919,3951],{"intervention":4425,"totalTrials":93,"cells":4426},"Doxapram Hydrochloride",{"EARLY_PHASE1":4427,"PHASE1":4429,"PHASE2":4431,"PHASE3":4433,"PHASE4":4435,"NA":4437},{"trials":4428,"activeCount":97},[],{"trials":4430,"activeCount":97},[],{"trials":4432,"activeCount":97},[],{"trials":4434,"activeCount":97},[],{"trials":4436,"activeCount":97},[],{"trials":4438,"activeCount":97},[4439],{"nctId":4440,"briefTitle":4441,"status":595,"phases":4442,"primaryCompletion":620,"completion":620,"start":3423,"enrollment":4443,"conditions":4444,"interventions":4446},"NCT03894189","The Effect of Doxapram Versus Theophylline on Diaphragmatic Function",[90],70,[4445],"Weaning Failure",[4425,4447],"Theophylline",{"intervention":4447,"totalTrials":93,"cells":4449},{"EARLY_PHASE1":4450,"PHASE1":4452,"PHASE2":4454,"PHASE3":4456,"PHASE4":4458,"NA":4460},{"trials":4451,"activeCount":97},[],{"trials":4453,"activeCount":97},[],{"trials":4455,"activeCount":97},[],{"trials":4457,"activeCount":97},[],{"trials":4459,"activeCount":97},[],{"trials":4461,"activeCount":97},[4462],{"nctId":4440,"briefTitle":4441,"status":595,"phases":4463,"primaryCompletion":620,"completion":620,"start":3423,"enrollment":4443,"conditions":4464,"interventions":4465},[90],[4445],[4425,4447]]